Protein,Protein_definition,Disease_category,Disease,NB_individual,NB_case,HR[95%CI],P_value
BID,BH3-interacting domain death agonist,Chapter I Certain infectious and parasitic diseases,"Bacterial infection, other or unspecified",27608,108,1.21 [0.96-1.52],0.1123062082406449
BID,BH3-interacting domain death agonist,Chapter I Certain infectious and parasitic diseases,"Bacterial intestinal infections, IBD co-morbidities",28185,145,1.10 [0.89-1.35],0.3862572345422876
BID,BH3-interacting domain death agonist,Chapter I Certain infectious and parasitic diseases,"Bacterial, viral and other infectious agents",27929,1005,1.09 [1.01-1.18],0.025928507311976
BID,BH3-interacting domain death agonist,Chapter I Certain infectious and parasitic diseases,Candidiasis,28219,301,1.04 [0.90-1.20],0.628604049402403
BID,BH3-interacting domain death agonist,Chapter I Certain infectious and parasitic diseases,Certain infectious and parasitic diseases,27418,2768,1.05 [1.00-1.11],0.0324318857985349
BID,BH3-interacting domain death agonist,Chapter I Certain infectious and parasitic diseases,Condition for Implicit Sepsis (Organ dysfunction codes),27679,2092,1.07 [1.02-1.14],0.0110177078711695
BID,BH3-interacting domain death agonist,Chapter I Certain infectious and parasitic diseases,Diarrhoea and gastroenteritis of presumed infectious origin,28005,1002,1.07 [0.99-1.16],0.079160649304533
BID,BH3-interacting domain death agonist,Chapter I Certain infectious and parasitic diseases,Enterocolitis due to Clostridium difficile,28133,44,0.94 [0.63-1.39],0.7502383402646093
BID,BH3-interacting domain death agonist,Chapter I Certain infectious and parasitic diseases,Explicit Sepsis,26950,648,1.07 [0.97-1.18],0.1908376896187579
BID,BH3-interacting domain death agonist,Chapter I Certain infectious and parasitic diseases,Implicit bacterial Sepsis,26057,622,1.07 [0.97-1.19],0.169256951047666
BID,BH3-interacting domain death agonist,Chapter I Certain infectious and parasitic diseases,Implicit fungal Sepsis,26297,169,0.99 [0.81-1.21],0.9129863576398044
BID,BH3-interacting domain death agonist,Chapter I Certain infectious and parasitic diseases,Implicit Sepsis,21021,1209,1.08 [1.01-1.16],0.0291951557393291
BID,BH3-interacting domain death agonist,Chapter I Certain infectious and parasitic diseases,Implicit viral Sepsis,26058,286,1.06 [0.91-1.23],0.4450633393740139
BID,BH3-interacting domain death agonist,Chapter I Certain infectious and parasitic diseases,Intestinal infectious diseases,28170,1167,1.08 [1.00-1.16],0.0408931237103654
BID,BH3-interacting domain death agonist,Chapter I Certain infectious and parasitic diseases,Mycoses,28280,362,1.06 [0.93-1.21],0.3673253156644592
BID,BH3-interacting domain death agonist,Chapter I Certain infectious and parasitic diseases,Other bacterial agents as the cause of diseases classified to other chapters,27538,614,1.16 [1.05-1.28],0.0026351172337863
BID,BH3-interacting domain death agonist,Chapter I Certain infectious and parasitic diseases,Other bacterial diseases,28216,716,1.07 [0.97-1.18],0.1548587320941882
BID,BH3-interacting domain death agonist,Chapter I Certain infectious and parasitic diseases,Other bacterial intestinal infections,27150,147,1.08 [0.88-1.33],0.467418036135765
BID,BH3-interacting domain death agonist,Chapter I Certain infectious and parasitic diseases,Other infectious diseases,28321,31,0.84 [0.52-1.36],0.4822128772502025
BID,BH3-interacting domain death agonist,Chapter I Certain infectious and parasitic diseases,Other septicaemia,28128,628,1.07 [0.96-1.18],0.2138042720000604
BID,BH3-interacting domain death agonist,Chapter I Certain infectious and parasitic diseases,Other specified/unspecified bacterial intestinal infections,28162,73,1.17 [0.88-1.56],0.280536999981274
BID,BH3-interacting domain death agonist,Chapter I Certain infectious and parasitic diseases,Other viral diseases,28225,174,1.18 [0.98-1.42],0.0803724341462538
BID,BH3-interacting domain death agonist,Chapter I Certain infectious and parasitic diseases,"Other viral diseases, not elsewhere classified",28209,158,1.16 [0.96-1.41],0.1338102931044192
BID,BH3-interacting domain death agonist,Chapter I Certain infectious and parasitic diseases,Streptococcus and staphylococcus as the cause of diseases classified to other chapters,27257,333,1.07 [0.94-1.23],0.3034745866074063
BID,BH3-interacting domain death agonist,Chapter I Certain infectious and parasitic diseases,Viral agents as the cause of diseases classified to other chapters,27168,244,1.01 [0.85-1.19],0.941826756290966
BID,BH3-interacting domain death agonist,Chapter I Certain infectious and parasitic diseases,Viral and other specified intestinal infections,27085,82,1.11 [0.84-1.47],0.4481431647072572
BID,BH3-interacting domain death agonist,Chapter I Certain infectious and parasitic diseases,Viral hepatitis,28294,54,0.85 [0.59-1.23],0.3929721002970174
BID,BH3-interacting domain death agonist,Chapter I Certain infectious and parasitic diseases,Viral infections characterized by skin and mucous membrane lesions,28257,130,0.82 [0.65-1.05],0.1114248838468062
BID,BH3-interacting domain death agonist,Chapter I Certain infectious and parasitic diseases,Viral warts,28171,44,0.74 [0.49-1.12],0.156411533048864
BID,BH3-interacting domain death agonist,Chapter I Certain infectious and parasitic diseases,Zoster [herpes zoster],28177,50,1.03 [0.71-1.48],0.8901427595638748
BID,BH3-interacting domain death agonist,Chapter II Neoplasms,Benign lipomatous neoplasm,28036,326,1.08 [0.93-1.24],0.3095369916696034
BID,BH3-interacting domain death agonist,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs,28228,77,1.26 [0.96-1.65],0.0971345092641332
BID,BH3-interacting domain death agonist,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk,28214,83,1.08 [0.82-1.43],0.5709679162142778
BID,BH3-interacting domain death agonist,Chapter II Neoplasms,Benign lipomatous neoplasm of spermatic cord,12640,45,0.95 [0.64-1.41],0.7877776150668768
BID,BH3-interacting domain death agonist,Chapter II Neoplasms,"Benign neoplasm of colon, rectum, anus and anal canal",28125,1209,1.00 [0.93-1.08],0.915658790869353
BID,BH3-interacting domain death agonist,Chapter II Neoplasms,Benign neoplasm of meninges,28309,51,1.27 [0.91-1.77],0.1664399603937845
BID,BH3-interacting domain death agonist,Chapter II Neoplasms,Benign neoplasm of other and ill-defined parts of digestive system,28284,52,1.12 [0.79-1.58],0.5261733881770133
BID,BH3-interacting domain death agonist,Chapter II Neoplasms,Benign neoplasm of other and unspecified endocrine glands,28298,96,1.08 [0.83-1.39],0.5708881895145148
BID,BH3-interacting domain death agonist,Chapter II Neoplasms,Benign neoplasm of ovary,15619,101,1.10 [0.86-1.41],0.4474773441793115
BID,BH3-interacting domain death agonist,Chapter II Neoplasms,Benign neoplasm: Ascending colon,28314,283,0.90 [0.77-1.06],0.2124080970803085
BID,BH3-interacting domain death agonist,Chapter II Neoplasms,Benign neoplasm: Caecum,28311,211,1.04 [0.87-1.24],0.6580467753966129
BID,BH3-interacting domain death agonist,Chapter II Neoplasms,"Benign neoplasm: Colon, unspecified",28251,60,0.97 [0.69-1.36],0.8523653976917518
BID,BH3-interacting domain death agonist,Chapter II Neoplasms,Benign neoplasm: Descending colon,28314,177,0.88 [0.72-1.07],0.1970057561772786
BID,BH3-interacting domain death agonist,Chapter II Neoplasms,Benign neoplasm: Rectum,28276,299,0.95 [0.82-1.11],0.5380720525848114
BID,BH3-interacting domain death agonist,Chapter II Neoplasms,Benign neoplasm: Sigmoid colon,28246,555,0.98 [0.88-1.10],0.7636577731860466
BID,BH3-interacting domain death agonist,Chapter II Neoplasms,Benign neoplasm: Transverse colon,28315,319,0.99 [0.86-1.15],0.8978189684784285
BID,BH3-interacting domain death agonist,Chapter II Neoplasms,Carcinoma in situ of breast,13434,87,0.69 [0.52-0.94],0.0164896342496515
BID,BH3-interacting domain death agonist,Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",13483,101,0.73 [0.55-0.96],0.0248634601352145
BID,BH3-interacting domain death agonist,Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",24477,32,0.82 [0.51-1.34],0.4316563026099164
BID,BH3-interacting domain death agonist,Chapter II Neoplasms,"Diffuse large B-cell lymphoma, excluding all cancers (controls excluding all cancers)",24484,39,0.62 [0.39-0.98],0.0403562467314249
BID,BH3-interacting domain death agonist,Chapter II Neoplasms,"Haemangioma and lymphangioma, any site",28278,114,1.21 [0.97-1.52],0.0941190410303154
BID,BH3-interacting domain death agonist,Chapter II Neoplasms,"Haemangioma, any site",28278,112,1.22 [0.97-1.54],0.0827517915166155
BID,BH3-interacting domain death agonist,Chapter II Neoplasms,Leiomyoma of uterus,14972,425,0.87 [0.77-0.99],0.035360419701598
BID,BH3-interacting domain death agonist,Chapter II Neoplasms,Lung cancer and mesothelioma,21036,179,1.27 [1.06-1.52],0.0101637540324568
BID,BH3-interacting domain death agonist,Chapter II Neoplasms,Lymphoid leukaemia,24474,29,1.23 [0.79-1.94],0.3590438214907721
BID,BH3-interacting domain death agonist,Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",24594,149,1.05 [0.85-1.29],0.673448546964597
BID,BH3-interacting domain death agonist,Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",24530,85,1.07 [0.82-1.42],0.6090205357861032
BID,BH3-interacting domain death agonist,Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",13534,81,1.00 [0.75-1.33],0.992395727627838
BID,BH3-interacting domain death agonist,Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",24498,53,1.05 [0.74-1.50],0.7867138991074044
BID,BH3-interacting domain death agonist,Chapter II Neoplasms,"Malignant neoplasm of kidney, except renal pelvis, excluding all cancers (controls excluding all cancers)",24513,68,0.86 [0.62-1.20],0.3833158993050605
BID,BH3-interacting domain death agonist,Chapter II Neoplasms,"Malignant neoplasm of oesophagus, excluding all cancers (controls excluding all cancers)",24517,72,1.05 [0.78-1.42],0.7454275681928566
BID,BH3-interacting domain death agonist,Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",13509,56,1.19 [0.86-1.65],0.294490925305061
BID,BH3-interacting domain death agonist,Chapter II Neoplasms,"Malignant neoplasm of pancreas, excluding all cancers (controls excluding all cancers)",24503,58,1.29 [0.94-1.76],0.1144845274096897
BID,BH3-interacting domain death agonist,Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",11410,418,1.08 [0.95-1.23],0.2249368062831963
BID,BH3-interacting domain death agonist,Chapter II Neoplasms,"Malignant neoplasm of rectum, excluding all cancers (controls excluding all cancers)",24536,91,1.13 [0.87-1.47],0.3630487791284378
BID,BH3-interacting domain death agonist,Chapter II Neoplasms,"Malignant neoplasm of stomach, excluding all cancers (controls excluding all cancers)",24502,57,1.26 [0.91-1.73],0.1652161413529614
BID,BH3-interacting domain death agonist,Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,24511,66,1.12 [0.82-1.53],0.4703361411207114
BID,BH3-interacting domain death agonist,Chapter II Neoplasms,Melanocytic naevi,28075,219,1.00 [0.84-1.19],0.9892853205273212
BID,BH3-interacting domain death agonist,Chapter II Neoplasms,Melanocytic naevi of trunk,28271,98,1.00 [0.77-1.30],0.9967842596497796
BID,BH3-interacting domain death agonist,Chapter II Neoplasms,Melanoma in situ,24460,52,1.15 [0.81-1.62],0.4394378986801168
BID,BH3-interacting domain death agonist,Chapter II Neoplasms,"Non-follicular lymphoma, hilmo, excluding all cancers",24506,61,0.72 [0.50-1.03],0.0709256302257273
BID,BH3-interacting domain death agonist,Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",24568,123,0.92 [0.72-1.17],0.4901744095224477
BID,BH3-interacting domain death agonist,Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",24569,124,1.31 [1.05-1.63],0.0165992415229462
BID,BH3-interacting domain death agonist,Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",24514,69,0.87 [0.63-1.20],0.3997798344845366
BID,BH3-interacting domain death agonist,Chapter II Neoplasms,Other benign neoplasms of skin,28134,145,1.12 [0.91-1.38],0.2740900544841327
BID,BH3-interacting domain death agonist,Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",25100,655,0.96 [0.87-1.07],0.4441520564602452
BID,BH3-interacting domain death agonist,Chapter II Neoplasms,"Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)",25132,687,0.96 [0.87-1.07],0.4709920185963367
BID,BH3-interacting domain death agonist,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Agranulocytosis,28044,289,0.93 [0.80-1.09],0.3758934526050177
BID,BH3-interacting domain death agonist,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Anaemia in chronic diseases classified elsewhere,26874,59,1.08 [0.78-1.51],0.6447061100619931
BID,BH3-interacting domain death agonist,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of spleen,27825,70,1.10 [0.81-1.48],0.5473834759214274
BID,BH3-interacting domain death agonist,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,27499,2266,1.02 [0.97-1.08],0.40322556447654
BID,BH3-interacting domain death agonist,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Folate deficiency anaemia,27110,23,0.72 [0.40-1.29],0.2728122328859295
BID,BH3-interacting domain death agonist,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Idiopathic thrombocytopenic purpura,27964,36,0.92 [0.59-1.42],0.7003180211289897
BID,BH3-interacting domain death agonist,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other anaemias,27869,1054,1.05 [0.97-1.13],0.2571019271842606
BID,BH3-interacting domain death agonist,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified anaemias,27869,1054,1.05 [0.97-1.13],0.2571019271842606
BID,BH3-interacting domain death agonist,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified aplastic anaemias,26873,58,1.05 [0.75-1.47],0.7921048205489123
BID,BH3-interacting domain death agonist,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified iron deficiency,28033,946,1.08 [0.99-1.17],0.0689756117175736
BID,BH3-interacting domain death agonist,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other coagulation defects,28038,110,0.86 [0.66-1.10],0.2317898057433944
BID,BH3-interacting domain death agonist,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other diseases of blood and blood-forming organs,27809,54,1.17 [0.84-1.62],0.3478289317409645
BID,BH3-interacting domain death agonist,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other disorders of white blood cells,27797,42,1.13 [0.77-1.66],0.5181240975768374
BID,BH3-interacting domain death agonist,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Purpura and other haemorrhagic conditions,28122,194,0.82 [0.67-0.99],0.040462974572651
BID,BH3-interacting domain death agonist,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Sarcoidosis,28238,69,1.25 [0.94-1.66],0.1301334025027537
BID,BH3-interacting domain death agonist,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,"Thrombocytopenia, unspecified",28090,162,0.74 [0.59-0.92],0.0065794605466354
BID,BH3-interacting domain death agonist,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Vitamin B12 deficiency anaemia,27160,73,1.03 [0.76-1.40],0.8324031560059849
BID,BH3-interacting domain death agonist,"Chapter IV Endocrine, nutritional and metabolic diseases",Acidosis,24333,218,1.11 [0.94-1.32],0.2019691517150968
BID,BH3-interacting domain death agonist,"Chapter IV Endocrine, nutritional and metabolic diseases",Acute alcohol intoxication,26354,129,1.11 [0.90-1.37],0.3392518537070356
BID,BH3-interacting domain death agonist,"Chapter IV Endocrine, nutritional and metabolic diseases",Alcohol dependence,26365,140,1.11 [0.90-1.37],0.3120172701039616
BID,BH3-interacting domain death agonist,"Chapter IV Endocrine, nutritional and metabolic diseases",Alkalosis,24153,38,1.47 [1.04-2.09],0.0308583895796239
BID,BH3-interacting domain death agonist,"Chapter IV Endocrine, nutritional and metabolic diseases",Bipolar affective disorders,26285,73,0.99 [0.73-1.33],0.92993209067778
BID,BH3-interacting domain death agonist,"Chapter IV Endocrine, nutritional and metabolic diseases",Deficiency of other B group vitamins,25947,155,1.09 [0.89-1.33],0.4050487638039126
BID,BH3-interacting domain death agonist,"Chapter IV Endocrine, nutritional and metabolic diseases","Delirium, not induced by alcohol and other psychoactive substances",28170,173,1.02 [0.84-1.25],0.809162393626484
BID,BH3-interacting domain death agonist,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in Alzheimer disease,28045,48,1.04 [0.71-1.50],0.8508538325333703
BID,BH3-interacting domain death agonist,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in other diseases classified elsewhere,28035,38,0.83 [0.53-1.29],0.4072067216475695
BID,BH3-interacting domain death agonist,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression,27899,1687,1.04 [0.98-1.11],0.187854503983756
BID,BH3-interacting domain death agonist,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression or dysthymia,25372,1636,1.05 [0.99-1.12],0.1370512429746624
BID,BH3-interacting domain death agonist,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of lipoprotein metabolism, unspecified",24157,42,1.36 [0.97-1.93],0.0783676100528968
BID,BH3-interacting domain death agonist,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of thyroid, unspecified",26608,58,0.68 [0.47-0.97],0.0358901548363047
BID,BH3-interacting domain death agonist,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of calcium metabolism,24304,189,1.23 [1.04-1.46],0.0186230644639329
BID,BH3-interacting domain death agonist,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of iron metabolism,24180,65,1.35 [1.02-1.78],0.0367915231980527
BID,BH3-interacting domain death agonist,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of lipoprotein metabolism and other lipidaemias,26568,2453,1.17 [1.11-1.23],9.039383333691063e-10
BID,BH3-interacting domain death agonist,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of magnesium metabolism,24236,121,1.22 [0.99-1.52],0.067413029121539
BID,BH3-interacting domain death agonist,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,24509,394,1.23 [1.09-1.38],0.0007482141896613
BID,BH3-interacting domain death agonist,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,28217,284,1.11 [0.96-1.29],0.1497268491948459
BID,BH3-interacting domain death agonist,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of parathyroid gland,28049,116,1.21 [0.96-1.51],0.0991228893912777
BID,BH3-interacting domain death agonist,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of phosphorus metabolism and phosphatases,24214,99,1.19 [0.93-1.51],0.1626114975056238
BID,BH3-interacting domain death agonist,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorders of plasma-protein metabolism, not elsewhere classified",24154,39,0.71 [0.46-1.11],0.1322271551623517
BID,BH3-interacting domain death agonist,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of the thyroid gland,27888,1338,1.07 [1.00-1.15],0.0481477973436121
BID,BH3-interacting domain death agonist,"Chapter IV Endocrine, nutritional and metabolic diseases",Fluid overload,24246,131,1.21 [0.98-1.49],0.0749892447114123
BID,BH3-interacting domain death agonist,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperkalaemia,24285,170,1.05 [0.87-1.28],0.586563904207515
BID,BH3-interacting domain death agonist,"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",24517,402,1.12 [0.99-1.26],0.0794022933127363
BID,BH3-interacting domain death agonist,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,24178,63,0.95 [0.68-1.32],0.7637086857254836
BID,BH3-interacting domain death agonist,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,28042,109,1.15 [0.91-1.46],0.2509264457403433
BID,BH3-interacting domain death agonist,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypo-osmolality and hyponatraemia,24416,301,1.08 [0.94-1.25],0.2920966149912782
BID,BH3-interacting domain death agonist,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypokalaemia,24411,296,1.11 [0.96-1.28],0.1725512118975697
BID,BH3-interacting domain death agonist,"Chapter IV Endocrine, nutritional and metabolic diseases",Iron deficiency,25852,60,0.99 [0.71-1.38],0.9409627605195702
BID,BH3-interacting domain death agonist,"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,27614,3499,1.13 [1.08-1.17],3.77655605031039e-08
BID,BH3-interacting domain death agonist,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic multinodular goitre,26588,38,0.70 [0.45-1.10],0.11838885102755
BID,BH3-interacting domain death agonist,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic single thyroid nodule,26612,62,1.02 [0.74-1.41],0.9103670733598646
BID,BH3-interacting domain death agonist,"Chapter IV Endocrine, nutritional and metabolic diseases",Obesity,28131,1972,1.02 [0.96-1.07],0.5980425690909363
BID,BH3-interacting domain death agonist,"Chapter IV Endocrine, nutritional and metabolic diseases","Obesity, other/unspecified",28135,1969,1.01 [0.96-1.07],0.6188961639242352
BID,BH3-interacting domain death agonist,"Chapter IV Endocrine, nutritional and metabolic diseases",Other and/or unspecified nontoxic goitre,26588,38,1.51 [1.06-2.16],0.0240002483091223
BID,BH3-interacting domain death agonist,"Chapter IV Endocrine, nutritional and metabolic diseases",Other anxiety disorders,27989,1263,1.01 [0.94-1.09],0.7348808547572987
BID,BH3-interacting domain death agonist,"Chapter IV Endocrine, nutritional and metabolic diseases","Other disorders of fluid, electrolyte and acid-base balance",25029,914,1.11 [1.02-1.21],0.0107437806960133
BID,BH3-interacting domain death agonist,"Chapter IV Endocrine, nutritional and metabolic diseases",Other disorders of glucose regulation and pancreatic internal secretion,28311,140,1.13 [0.92-1.39],0.2293690610853557
BID,BH3-interacting domain death agonist,"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,28032,35,1.15 [0.75-1.74],0.523081051432547
BID,BH3-interacting domain death agonist,"Chapter IV Endocrine, nutritional and metabolic diseases",Panic disorder,26817,91,1.20 [0.93-1.54],0.1608716694453331
BID,BH3-interacting domain death agonist,"Chapter IV Endocrine, nutritional and metabolic diseases",Phobic anxiety disorders,26846,120,1.13 [0.90-1.41],0.3056623685186679
BID,BH3-interacting domain death agonist,"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",24250,135,1.24 [1.01-1.53],0.0424121548711595
BID,BH3-interacting domain death agonist,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes without complications,26482,121,1.12 [0.90-1.41],0.3162052364726267
BID,BH3-interacting domain death agonist,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,1749,72,0.95 [0.70-1.28],0.7254163786662668
BID,BH3-interacting domain death agonist,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,1858,196,1.04 [0.87-1.25],0.6347173195527036
BID,BH3-interacting domain death agonist,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,26402,41,0.85 [0.55-1.29],0.4407049355753393
BID,BH3-interacting domain death agonist,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,1714,37,1.07 [0.71-1.62],0.7319433328224165
BID,BH3-interacting domain death agonist,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,27889,1528,1.19 [1.12-1.26],6.562332309947674e-08
BID,BH3-interacting domain death agonist,"Chapter IV Endocrine, nutritional and metabolic diseases",Unspecified dementia,28070,73,0.76 [0.55-1.05],0.0996201834446063
BID,BH3-interacting domain death agonist,"Chapter IV Endocrine, nutritional and metabolic diseases",Vitamin D deficiency,26073,281,0.95 [0.82-1.11],0.5429299782965978
BID,BH3-interacting domain death agonist,"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,24532,417,1.11 [0.99-1.26],0.0860234952567057
BID,BH3-interacting domain death agonist,Chapter IX Diseases of the circulatory system,"!Phlebitis/thrombophlebitis venae iliacae [externae/internae/communis], drug-induced",28233,179,0.89 [0.73-1.09],0.2544876497524433
BID,BH3-interacting domain death agonist,Chapter IX Diseases of the circulatory system,Abdominal aortic aneurysm (AAA),27578,58,0.93 [0.66-1.33],0.705795695396009
BID,BH3-interacting domain death agonist,Chapter IX Diseases of the circulatory system,Angina pectoris,27021,812,1.06 [0.97-1.16],0.1708541135332684
BID,BH3-interacting domain death agonist,Chapter IX Diseases of the circulatory system,Aortic aneurysm,27625,105,1.04 [0.81-1.33],0.7811557045710089
BID,BH3-interacting domain death agonist,Chapter IX Diseases of the circulatory system,Arterial embolism and thrombosis of lower extremity artery,27550,30,1.30 [0.86-1.97],0.2111407709963827
BID,BH3-interacting domain death agonist,Chapter IX Diseases of the circulatory system,"Atherosclerosis, excluding cerebral and coronary sclerosis",27628,108,1.12 [0.88-1.41],0.3637626422618467
BID,BH3-interacting domain death agonist,Chapter IX Diseases of the circulatory system,Atrial fibrillation and flutter,20212,964,1.05 [0.96-1.13],0.2839370285717363
BID,BH3-interacting domain death agonist,Chapter IX Diseases of the circulatory system,AV-block,25781,189,1.01 [0.84-1.22],0.9299286184005549
BID,BH3-interacting domain death agonist,Chapter IX Diseases of the circulatory system,"Bradycardia, unspecified, drug-induced",28288,265,0.89 [0.76-1.05],0.1642484247177482
BID,BH3-interacting domain death agonist,Chapter IX Diseases of the circulatory system,Cardiac arrest,19364,116,1.33 [1.08-1.64],0.0077848351965481
BID,BH3-interacting domain death agonist,Chapter IX Diseases of the circulatory system,Cardiomyopathy,25729,137,1.06 [0.86-1.32],0.5789414786672774
BID,BH3-interacting domain death agonist,Chapter IX Diseases of the circulatory system,"Cardiomyopathy, other and unspecified",25674,82,0.93 [0.69-1.25],0.6325508170132588
BID,BH3-interacting domain death agonist,Chapter IX Diseases of the circulatory system,Cerebral atherosclerosis,28323,21,0.84 [0.46-1.53],0.5622999648663505
BID,BH3-interacting domain death agonist,Chapter IX Diseases of the circulatory system,Conduction disorders,26137,545,1.06 [0.95-1.18],0.3216236734167406
BID,BH3-interacting domain death agonist,Chapter IX Diseases of the circulatory system,Coronary atherosclerosis,27587,1389,1.18 [1.11-1.26],4.448017043411552e-07
BID,BH3-interacting domain death agonist,Chapter IX Diseases of the circulatory system,Death due to cardiac causes,26340,6172,1.10 [1.06-1.13],2.069058688037833e-08
BID,BH3-interacting domain death agonist,Chapter IX Diseases of the circulatory system,DVT of lower extremities,27133,186,0.85 [0.70-1.04],0.1158548923529997
BID,BH3-interacting domain death agonist,Chapter IX Diseases of the circulatory system,Endocarditis,25635,43,1.02 [0.69-1.51],0.936106158671907
BID,BH3-interacting domain death agonist,Chapter IX Diseases of the circulatory system,"Heart failure, strict",28203,521,1.12 [1.00-1.25],0.0458835141225859
BID,BH3-interacting domain death agonist,Chapter IX Diseases of the circulatory system,Hypertension,26930,5015,1.11 [1.08-1.15],1.947368126128924e-09
BID,BH3-interacting domain death agonist,Chapter IX Diseases of the circulatory system,"Hypertension, essential",26947,5032,1.11 [1.08-1.15],2.1746992336075903e-09
BID,BH3-interacting domain death agonist,Chapter IX Diseases of the circulatory system,"Hypertension, portal",28153,59,0.63 [0.44-0.92],0.0166714961218683
BID,BH3-interacting domain death agonist,Chapter IX Diseases of the circulatory system,"Hypertension, Pulmonary Arterial",22005,90,0.94 [0.71-1.24],0.6459205036815311
BID,BH3-interacting domain death agonist,Chapter IX Diseases of the circulatory system,Hypertensive Renal Disease,21977,62,1.15 [0.84-1.58],0.3747987378376927
BID,BH3-interacting domain death agonist,Chapter IX Diseases of the circulatory system,Hypotension,28217,714,1.07 [0.97-1.17],0.1776713694038271
BID,BH3-interacting domain death agonist,Chapter IX Diseases of the circulatory system,Intracerebral haemorrhage,27782,63,0.98 [0.70-1.37],0.9133724052588
BID,BH3-interacting domain death agonist,Chapter IX Diseases of the circulatory system,"Ischaemic heart disease, wide definition",27756,1547,1.15 [1.08-1.22],1.991366821085218e-05
BID,BH3-interacting domain death agonist,Chapter IX Diseases of the circulatory system,"Ischaemic Stroke, excluding all haemorrhages",28087,309,1.04 [0.90-1.21],0.5629852920865801
BID,BH3-interacting domain death agonist,Chapter IX Diseases of the circulatory system,Left bundle-branch block,25788,196,1.17 [0.98-1.39],0.0863463368452978
BID,BH3-interacting domain death agonist,Chapter IX Diseases of the circulatory system,Major coronary heart disease event,28058,614,1.19 [1.08-1.31],0.0005701204502747
BID,BH3-interacting domain death agonist,Chapter IX Diseases of the circulatory system,"Myocardial infarction, strict",26710,501,1.20 [1.07-1.33],0.0012016235535957
BID,BH3-interacting domain death agonist,Chapter IX Diseases of the circulatory system,"Myocardial infarction, with ST-elevation",28264,123,1.04 [0.82-1.31],0.748662973957777
BID,BH3-interacting domain death agonist,Chapter IX Diseases of the circulatory system,"Myocardial infarction, without ST-elevation",28307,209,1.13 [0.95-1.34],0.1685234916308277
BID,BH3-interacting domain death agonist,Chapter IX Diseases of the circulatory system,Oesophageal varices,26989,42,0.66 [0.42-1.02],0.0621326112268511
BID,BH3-interacting domain death agonist,Chapter IX Diseases of the circulatory system,Other aneurysm,27572,52,0.82 [0.56-1.19],0.2944653790843024
BID,BH3-interacting domain death agonist,Chapter IX Diseases of the circulatory system,Other arrhythmias,25835,243,0.99 [0.84-1.17],0.929656309376786
BID,BH3-interacting domain death agonist,Chapter IX Diseases of the circulatory system,Other arterial embolism and thrombosis,27583,63,1.30 [0.98-1.74],0.073558049869672
BID,BH3-interacting domain death agonist,Chapter IX Diseases of the circulatory system,Other diseases of arteries and capillaries,27664,144,0.88 [0.71-1.10],0.2725791742757331
BID,BH3-interacting domain death agonist,Chapter IX Diseases of the circulatory system,Other diseases of pericardium,25721,129,0.93 [0.74-1.17],0.529379423092817
BID,BH3-interacting domain death agonist,Chapter IX Diseases of the circulatory system,Other disorders of veins,27021,74,0.89 [0.66-1.22],0.4749478877243576
BID,BH3-interacting domain death agonist,Chapter IX Diseases of the circulatory system,Other embolism and thrombosis,26995,48,1.09 [0.76-1.56],0.6431246294117058
BID,BH3-interacting domain death agonist,Chapter IX Diseases of the circulatory system,Other intracranial haemorrhages,27534,37,1.09 [0.72-1.65],0.6847519577673337
BID,BH3-interacting domain death agonist,Chapter IX Diseases of the circulatory system,Other noninfective disorders of lymphatic vessels and lymph nodes,27040,93,0.95 [0.72-1.24],0.6923538159973682
BID,BH3-interacting domain death agonist,Chapter IX Diseases of the circulatory system,Other or ill-defined heart diseases,26190,598,1.04 [0.93-1.15],0.5057675193119956
BID,BH3-interacting domain death agonist,Chapter IX Diseases of the circulatory system,Other other unspecified disorders of the circulatory system,27552,49,0.65 [0.43-0.97],0.0370079240840303
BID,BH3-interacting domain death agonist,Chapter IX Diseases of the circulatory system,Other peripheral vascular diseases,27865,345,1.09 [0.96-1.25],0.1943269671151393
BID,BH3-interacting domain death agonist,Chapter IX Diseases of the circulatory system,Other pulmonary heart/vessel disease,27867,159,1.07 [0.87-1.30],0.5388368905817662
BID,BH3-interacting domain death agonist,Chapter IX Diseases of the circulatory system,"Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere",27734,237,0.98 [0.83-1.17],0.8491753803439511
BID,BH3-interacting domain death agonist,Chapter IX Diseases of the circulatory system,Paroxysmal tachycardia,19506,258,0.86 [0.73-1.01],0.0699106644411579
BID,BH3-interacting domain death agonist,Chapter IX Diseases of the circulatory system,Peripheral artery disease,27707,212,1.07 [0.90-1.27],0.4523375209061225
BID,BH3-interacting domain death agonist,Chapter IX Diseases of the circulatory system,Phlebitis and thrombophlebitis (not including DVT),27206,259,0.86 [0.73-1.01],0.0728964668433909
BID,BH3-interacting domain death agonist,Chapter IX Diseases of the circulatory system,Pulmonary embolism,28054,346,0.93 [0.80-1.07],0.2909096712422896
BID,BH3-interacting domain death agonist,Chapter IX Diseases of the circulatory system,Rheumatic valve diseases,28282,334,0.98 [0.85-1.13],0.8161250534345759
BID,BH3-interacting domain death agonist,Chapter IX Diseases of the circulatory system,Right bundle-branch block,25773,181,0.96 [0.79-1.17],0.6915664684697761
BID,BH3-interacting domain death agonist,Chapter IX Diseases of the circulatory system,Secondary right heart disease,27863,155,1.02 [0.83-1.25],0.8805375886334079
BID,BH3-interacting domain death agonist,Chapter IX Diseases of the circulatory system,Sequelae of cerebrovascular disease,27616,119,1.01 [0.80-1.28],0.911426139354194
BID,BH3-interacting domain death agonist,Chapter IX Diseases of the circulatory system,"Stroke, excluding SAH",28080,361,1.03 [0.90-1.18],0.6518169232007951
BID,BH3-interacting domain death agonist,Chapter IX Diseases of the circulatory system,"Stroke, including SAH",28053,396,1.03 [0.91-1.17],0.6416704676681694
BID,BH3-interacting domain death agonist,Chapter IX Diseases of the circulatory system,Subarachnoid haemorrhage,27758,53,0.94 [0.65-1.36],0.7491573419833675
BID,BH3-interacting domain death agonist,Chapter IX Diseases of the circulatory system,Thoracic aortic aneurysm,27574,55,0.91 [0.64-1.31],0.6285115182116394
BID,BH3-interacting domain death agonist,Chapter IX Diseases of the circulatory system,Transient ischemic attack,27926,148,0.99 [0.80-1.22],0.9123909485409624
BID,BH3-interacting domain death agonist,Chapter IX Diseases of the circulatory system,Unstable angina pectoris,27628,184,1.18 [0.98-1.41],0.0787431161633247
BID,BH3-interacting domain death agonist,Chapter IX Diseases of the circulatory system,Varicose veins,27271,324,0.80 [0.69-0.93],0.0044400959109919
BID,BH3-interacting domain death agonist,Chapter IX Diseases of the circulatory system,Vascular diseases of the intestine,27529,48,0.95 [0.65-1.38],0.7839191837154066
BID,BH3-interacting domain death agonist,Chapter IX Diseases of the circulatory system,Venous thromboembolism,28146,543,0.90 [0.81-1.01],0.0780862958878516
BID,BH3-interacting domain death agonist,Chapter V Mental and behavioural disorders,"Alcohol use disorder, ICD-based",28164,384,1.03 [0.90-1.17],0.6871287756337966
BID,BH3-interacting domain death agonist,Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",25244,1451,1.04 [0.98-1.12],0.202073036314557
BID,BH3-interacting domain death agonist,Chapter V Mental and behavioural disorders,Any mental disorder,27551,3758,1.04 [1.00-1.08],0.0576250390991326
BID,BH3-interacting domain death agonist,Chapter V Mental and behavioural disorders,"Mental and behavioural disorders due to alcohol, excluding acute intoxication",28098,455,1.05 [0.94-1.19],0.3756544996027424
BID,BH3-interacting domain death agonist,Chapter V Mental and behavioural disorders,"Mood disorders, excluding more controls",25509,1716,1.05 [0.98-1.11],0.1405634227663439
BID,BH3-interacting domain death agonist,Chapter V Mental and behavioural disorders,"Schizophrenia or delusion, excluding more controls",23887,94,0.97 [0.75-1.27],0.8434806602245656
BID,BH3-interacting domain death agonist,Chapter V Mental and behavioural disorders,Smoking dependency,27772,1555,1.07 [1.01-1.14],0.0330599377666507
BID,BH3-interacting domain death agonist,Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",25598,1805,1.06 [1.00-1.13],0.0398859054814186
BID,BH3-interacting domain death agonist,Chapter V Mental and behavioural disorders,Vascular dementia,28204,22,0.88 [0.50-1.55],0.6598445013362437
BID,BH3-interacting domain death agonist,Chapter VI Diseases of the nervous system,Alzheimer disease,28323,66,1.02 [0.74-1.40],0.9180234964816156
BID,BH3-interacting domain death agonist,Chapter VI Diseases of the nervous system,Bell's palsy,26622,76,1.12 [0.85-1.49],0.4177498189969079
BID,BH3-interacting domain death agonist,Chapter VI Diseases of the nervous system,Carpal tunnel syndrome,27038,492,1.03 [0.92-1.16],0.5803076763851416
BID,BH3-interacting domain death agonist,Chapter VI Diseases of the nervous system,Cerebral cysts,27966,213,1.04 [0.87-1.23],0.6957054729148862
BID,BH3-interacting domain death agonist,Chapter VI Diseases of the nervous system,Cerebral palsy and other paralytic syndromes,28237,232,1.04 [0.88-1.23],0.6414319208920094
BID,BH3-interacting domain death agonist,Chapter VI Diseases of the nervous system,Circumscribed brain atrophy,28178,24,0.58 [0.32-1.03],0.0647071879535037
BID,BH3-interacting domain death agonist,Chapter VI Diseases of the nervous system,Diseases of the myoneural junction and muscle,28308,52,1.05 [0.74-1.50],0.7856536964383151
BID,BH3-interacting domain death agonist,Chapter VI Diseases of the nervous system,"Disorders of brain, other and unspecified",27814,61,1.02 [0.74-1.42],0.8860389657104573
BID,BH3-interacting domain death agonist,Chapter VI Diseases of the nervous system,Epilepsy,26720,266,1.05 [0.90-1.23],0.554450033648862
BID,BH3-interacting domain death agonist,Chapter VI Diseases of the nervous system,Episodal and paroxysmal disorders,27827,1373,1.04 [0.97-1.11],0.2505744151115126
BID,BH3-interacting domain death agonist,Chapter VI Diseases of the nervous system,Extrapyramidal and movement disorders,28293,275,1.09 [0.93-1.27],0.2950839065174594
BID,BH3-interacting domain death agonist,Chapter VI Diseases of the nervous system,Falls/tendency to fall,27794,1682,1.00 [0.94-1.07],0.924815036109928
BID,BH3-interacting domain death agonist,Chapter VI Diseases of the nervous system,Generalized epilepsy,27943,54,0.94 [0.65-1.34],0.7140758164282495
BID,BH3-interacting domain death agonist,Chapter VI Diseases of the nervous system,Hemiplegia,28171,166,1.00 [0.82-1.22],0.9873378364048266
BID,BH3-interacting domain death agonist,Chapter VI Diseases of the nervous system,Hydrocephalus,27800,47,1.19 [0.84-1.70],0.3262293592632347
BID,BH3-interacting domain death agonist,Chapter VI Diseases of the nervous system,Inflammatory diseases of the central nervous system,28299,64,0.99 [0.72-1.37],0.951383446987505
BID,BH3-interacting domain death agonist,Chapter VI Diseases of the nervous system,Lesion of plantar nerve,26629,83,1.15 [0.87-1.51],0.3282832417512594
BID,BH3-interacting domain death agonist,Chapter VI Diseases of the nervous system,Lesion of ulnar nerve,26633,87,1.22 [0.94-1.58],0.1291695195238129
BID,BH3-interacting domain death agonist,Chapter VI Diseases of the nervous system,Memory loss,28168,74,0.98 [0.73-1.33],0.9101209118535664
BID,BH3-interacting domain death agonist,Chapter VI Diseases of the nervous system,Migraine,26886,432,1.08 [0.95-1.22],0.2328280860660974
BID,BH3-interacting domain death agonist,Chapter VI Diseases of the nervous system,"Migraine, unspecified, drug-induced",28230,383,1.06 [0.93-1.21],0.3781195587348367
BID,BH3-interacting domain death agonist,Chapter VI Diseases of the nervous system,Motor neuron disease,20629,97,1.21 [0.95-1.55],0.1309054379377333
BID,BH3-interacting domain death agonist,Chapter VI Diseases of the nervous system,MS-disease / Multiple Sclerosis,28123,146,0.92 [0.74-1.15],0.4789626021370592
BID,BH3-interacting domain death agonist,Chapter VI Diseases of the nervous system,"Nerve, nerve root and plexus disorders",27705,1159,1.08 [1.00-1.16],0.0420593668694284
BID,BH3-interacting domain death agonist,Chapter VI Diseases of the nervous system,Neurological diseases,26866,3147,1.04 [0.99-1.09],0.1172927634757722
BID,BH3-interacting domain death agonist,Chapter VI Diseases of the nervous system,Other and unspecified degenerative diseases of nervous system,28231,77,1.04 [0.78-1.40],0.7780335277649822
BID,BH3-interacting domain death agonist,Chapter VI Diseases of the nervous system,"Other and unspecified nerve root and plexus disorders, also in other diseases",26938,392,1.10 [0.97-1.25],0.1268597324099994
BID,BH3-interacting domain death agonist,Chapter VI Diseases of the nervous system,"Other and unspecified polyneuropathies, also in other diseases",28248,242,1.03 [0.88-1.21],0.7177655499235207
BID,BH3-interacting domain death agonist,Chapter VI Diseases of the nervous system,Other degenerative diseases of the nervous system,23637,312,0.94 [0.81-1.09],0.4010806500017772
BID,BH3-interacting domain death agonist,Chapter VI Diseases of the nervous system,Other diseases of spinal cord,27813,60,1.01 [0.72-1.41],0.9489174719624344
BID,BH3-interacting domain death agonist,Chapter VI Diseases of the nervous system,Other disorders of nervous system,27870,117,1.13 [0.90-1.42],0.3072359326181206
BID,BH3-interacting domain death agonist,Chapter VI Diseases of the nervous system,Other extrapyramidal and movement disorders in other diseases,28109,91,1.13 [0.87-1.46],0.3757902882855334
BID,BH3-interacting domain death agonist,Chapter VI Diseases of the nervous system,Other facial nerve disorders,26640,94,1.15 [0.90-1.49],0.2653107369276239
BID,BH3-interacting domain death agonist,Chapter VI Diseases of the nervous system,Other headache syndromes,26516,62,1.17 [0.85-1.59],0.3358071092764161
BID,BH3-interacting domain death agonist,Chapter VI Diseases of the nervous system,Other neurological diseases,28203,450,1.12 [0.99-1.26],0.0643178341619703
BID,BH3-interacting domain death agonist,Chapter VI Diseases of the nervous system,Other sleep disorders,27049,595,1.03 [0.92-1.14],0.6373741416340116
BID,BH3-interacting domain death agonist,Chapter VI Diseases of the nervous system,Parkinson's disease,28310,163,1.03 [0.84-1.26],0.7868191897201289
BID,BH3-interacting domain death agonist,Chapter VI Diseases of the nervous system,Postviral fatigue syndrome,27819,66,1.17 [0.86-1.58],0.3164579951965948
BID,BH3-interacting domain death agonist,Chapter VI Diseases of the nervous system,Restless leg syndrome,28322,46,1.20 [0.84-1.72],0.3202608764258712
BID,BH3-interacting domain death agonist,Chapter VI Diseases of the nervous system,Sleep apnoea,28069,516,1.02 [0.92-1.15],0.6710127190052046
BID,BH3-interacting domain death agonist,Chapter VI Diseases of the nervous system,Small fibre neuropathy,28043,37,1.11 [0.74-1.66],0.6173280176098664
BID,BH3-interacting domain death agonist,Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,28308,124,1.09 [0.87-1.36],0.4653767757388753
BID,BH3-interacting domain death agonist,Chapter VI Diseases of the nervous system,Trigeminal neuralgia,26579,33,1.03 [0.65-1.61],0.911618935294054
BID,BH3-interacting domain death agonist,Chapter VI Diseases of the nervous system,Unspecific neurodegenerative disorder,28323,67,1.04 [0.76-1.42],0.8068700638155526
BID,BH3-interacting domain death agonist,Chapter VI Diseases of the nervous system,Vascular dementia (undefined),28192,21,0.89 [0.50-1.59],0.6969247907991496
BID,BH3-interacting domain death agonist,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Amblyopia ex anopsia,27837,42,1.04 [0.70-1.54],0.8539288125372859
BID,BH3-interacting domain death agonist,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Astigmatism,27970,221,0.94 [0.79-1.12],0.488757808602596
BID,BH3-interacting domain death agonist,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Background diabetic retinopathy,28233,200,1.13 [0.95-1.35],0.1594164806292128
BID,BH3-interacting domain death agonist,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Blepharochalasis,27560,37,0.97 [0.63-1.49],0.8967421224638003
BID,BH3-interacting domain death agonist,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Chalazion,27600,77,1.31 [1.00-1.71],0.0495092537101149
BID,BH3-interacting domain death agonist,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Conjunctivitis (acute, non atopic)",28230,30,1.03 [0.65-1.64],0.8980157534632169
BID,BH3-interacting domain death agonist,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Corneal degeneration,28117,66,1.13 [0.83-1.53],0.4525853043764306
BID,BH3-interacting domain death agonist,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",1720,43,1.16 [0.80-1.69],0.4261647681744274
BID,BH3-interacting domain death agonist,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diabetic neuropathy,2032,88,0.89 [0.68-1.18],0.4185515812553105
BID,BH3-interacting domain death agonist,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diplopia,27873,78,0.97 [0.72-1.30],0.8239269651709363
BID,BH3-interacting domain death agonist,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of choroid and retina,28193,639,1.03 [0.93-1.14],0.6012882664603221
BID,BH3-interacting domain death agonist,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of eyelid, lacrimal system and orbit",28013,490,0.91 [0.81-1.03],0.1362035824478236
BID,BH3-interacting domain death agonist,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of lacrimal system,27662,139,0.78 [0.62-0.98],0.0321898418641215
BID,BH3-interacting domain death agonist,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of ocular muscles, binocular movement, accommodation and refraction",28230,481,0.99 [0.88-1.11],0.8385573783531353
BID,BH3-interacting domain death agonist,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of optic nerve and visual pathways,28310,53,0.90 [0.62-1.29],0.5573690428577203
BID,BH3-interacting domain death agonist,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of refraction and accommodation,28157,408,1.00 [0.88-1.14],0.9965863202234516
BID,BH3-interacting domain death agonist,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of sclera, cornea, iris and ciliary body",28279,228,0.98 [0.83-1.17],0.8597584230242135
BID,BH3-interacting domain death agonist,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,28257,133,0.85 [0.67-1.08],0.180881652457229
BID,BH3-interacting domain death agonist,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ectropion of eyelid,27540,17,0.93 [0.49-1.79],0.8363034468866211
BID,BH3-interacting domain death agonist,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Entropion and trichiasis of eyelid,27553,30,0.88 [0.54-1.44],0.6016138158300404
BID,BH3-interacting domain death agonist,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Epiphora,27556,33,0.59 [0.36-0.96],0.0355093268174986
BID,BH3-interacting domain death agonist,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma,28274,397,1.03 [0.90-1.17],0.7048803133675827
BID,BH3-interacting domain death agonist,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma suspect,27980,103,0.93 [0.72-1.21],0.6137303713594753
BID,BH3-interacting domain death agonist,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Hypermetropia,27776,27,1.54 [1.01-2.34],0.0428811287842583
BID,BH3-interacting domain death agonist,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Iridocyclitis,28127,76,1.11 [0.83-1.48],0.4852195425712722
BID,BH3-interacting domain death agonist,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Keratitis,28204,153,0.92 [0.75-1.15],0.4768373915179118
BID,BH3-interacting domain death agonist,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Myopia,27912,163,1.02 [0.83-1.25],0.8482155623310323
BID,BH3-interacting domain death agonist,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified disorders of vitreous body,28202,78,0.90 [0.66-1.21],0.474694162320457
BID,BH3-interacting domain death agonist,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified glaucoma,28138,261,1.12 [0.96-1.31],0.1539502245285718
BID,BH3-interacting domain death agonist,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,27914,119,1.01 [0.80-1.28],0.9286055371425752
BID,BH3-interacting domain death agonist,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other cataract,27596,1083,1.03 [0.95-1.11],0.4959554532596463
BID,BH3-interacting domain death agonist,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of cornea,28177,126,0.95 [0.75-1.20],0.6442739086795486
BID,BH3-interacting domain death agonist,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eye and adnexa,28297,113,0.86 [0.67-1.11],0.2572953187646496
BID,BH3-interacting domain death agonist,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eyelid,27794,271,0.93 [0.79-1.09],0.3700467439053847
BID,BH3-interacting domain death agonist,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of iris and ciliary body,28089,38,1.04 [0.68-1.57],0.868768903710343
BID,BH3-interacting domain death agonist,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of optic [2nd] nerve and visual pathways,28293,36,0.98 [0.63-1.51],0.9249820825469538
BID,BH3-interacting domain death agonist,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other inflammation of eyelid,27564,41,0.95 [0.63-1.44],0.8074972574431796
BID,BH3-interacting domain death agonist,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified  disorders of eyelid,27643,120,0.92 [0.72-1.17],0.4766883864770436
BID,BH3-interacting domain death agonist,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified retinal disorders,27626,72,0.90 [0.66-1.24],0.5175086439001312
BID,BH3-interacting domain death agonist,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other strabismus,27806,57,1.01 [0.71-1.42],0.9763543368016048
BID,BH3-interacting domain death agonist,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Other, unspecified and serous retinal detachments",27606,52,0.96 [0.66-1.38],0.8067971932180183
BID,BH3-interacting domain death agonist,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Primary angle-closure glaucoma,27935,58,1.08 [0.77-1.51],0.6677570252790868
BID,BH3-interacting domain death agonist,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Primary open-angle glaucoma, strict",27971,94,1.01 [0.78-1.32],0.9271822906139536
BID,BH3-interacting domain death agonist,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ptosis of eyelid,27617,94,1.09 [0.84-1.41],0.5326471321850146
BID,BH3-interacting domain death agonist,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal detachment with retinal break,27680,126,1.04 [0.83-1.31],0.7223949227685087
BID,BH3-interacting domain death agonist,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal vascular occlusion,27591,37,0.95 [0.62-1.46],0.8157407043799868
BID,BH3-interacting domain death agonist,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Senile cataract,27361,848,1.01 [0.92-1.10],0.8289973137044754
BID,BH3-interacting domain death agonist,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Stenosis and insufficiency of lacrimal passages,27573,50,0.66 [0.44-0.98],0.0387913511234077
BID,BH3-interacting domain death agonist,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual disturbances,28107,312,1.01 [0.88-1.17],0.8649048263364818
BID,BH3-interacting domain death agonist,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,27833,38,0.72 [0.46-1.13],0.1549413345859984
BID,BH3-interacting domain death agonist,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),27925,130,1.12 [0.90-1.39],0.3238909637978304
BID,BH3-interacting domain death agonist,Chapter VIII Diseases of the ear and mastoid process,Benign paroxysmal vertigo,28128,63,0.78 [0.55-1.10],0.1573173207593957
BID,BH3-interacting domain death agonist,Chapter VIII Diseases of the ear and mastoid process,Diseases of external ear,28280,95,1.12 [0.87-1.45],0.3792063813862896
BID,BH3-interacting domain death agonist,Chapter VIII Diseases of the ear and mastoid process,Diseases of middle ear and mastoid,28198,140,0.93 [0.74-1.16],0.5159275372978709
BID,BH3-interacting domain death agonist,Chapter VIII Diseases of the ear and mastoid process,Labyrinthitis,28119,54,1.14 [0.81-1.60],0.4425030476452868
BID,BH3-interacting domain death agonist,Chapter VIII Diseases of the ear and mastoid process,Mnire disease,28119,54,0.93 [0.65-1.33],0.6975367023204002
BID,BH3-interacting domain death agonist,Chapter VIII Diseases of the ear and mastoid process,Other disorders of ear,28232,541,1.05 [0.94-1.17],0.3582135264507482
BID,BH3-interacting domain death agonist,Chapter VIII Diseases of the ear and mastoid process,Other specified/unspecified hearing loss,28026,335,1.08 [0.94-1.24],0.2787164261539168
BID,BH3-interacting domain death agonist,Chapter VIII Diseases of the ear and mastoid process,Sensorineural hearing loss,27790,99,1.05 [0.81-1.36],0.69897610061937
BID,BH3-interacting domain death agonist,Chapter VIII Diseases of the ear and mastoid process,Tinnitus,27772,81,1.11 [0.84-1.47],0.4711024614830881
BID,BH3-interacting domain death agonist,Chapter X Diseases of the respiratory system,Acute pharyngitis,28024,83,0.66 [0.48-0.89],0.0073175801053418
BID,BH3-interacting domain death agonist,Chapter X Diseases of the respiratory system,Acute upper respiratory infections,28181,240,0.85 [0.72-1.01],0.0663463749627728
BID,BH3-interacting domain death agonist,Chapter X Diseases of the respiratory system,Acute upper respiratory infections of multiple and unspecified sites,28006,65,0.84 [0.60-1.17],0.2920627111088162
BID,BH3-interacting domain death agonist,Chapter X Diseases of the respiratory system,All influenza,26988,79,0.85 [0.63-1.15],0.3045019983836945
BID,BH3-interacting domain death agonist,Chapter X Diseases of the respiratory system,All influenza (not pneumonia),26986,77,0.88 [0.65-1.19],0.4044419033341582
BID,BH3-interacting domain death agonist,Chapter X Diseases of the respiratory system,Allergic asthma (mode),20987,130,1.13 [0.91-1.40],0.2780440518596981
BID,BH3-interacting domain death agonist,Chapter X Diseases of the respiratory system,Allergic rhinitis,28167,320,1.18 [1.03-1.35],0.0176597746653433
BID,BH3-interacting domain death agonist,Chapter X Diseases of the respiratory system,"Asthma, excluding more controls",22519,1807,1.07 [1.01-1.14],0.0212937817789116
BID,BH3-interacting domain death agonist,Chapter X Diseases of the respiratory system,"Asthma, unspecified (mode)",22634,1777,1.08 [1.02-1.14],0.0139882475174275
BID,BH3-interacting domain death agonist,Chapter X Diseases of the respiratory system,Bacterial pneumonia (organism specified),28032,98,1.13 [0.88-1.45],0.3264984684746464
BID,BH3-interacting domain death agonist,Chapter X Diseases of the respiratory system,"Bacterial pneumonia, not elsewhere classified",26967,58,1.02 [0.73-1.42],0.9289962626194668
BID,BH3-interacting domain death agonist,Chapter X Diseases of the respiratory system,Bronchiectasis,25202,186,0.99 [0.81-1.20],0.8959044177370769
BID,BH3-interacting domain death agonist,Chapter X Diseases of the respiratory system,"Bronchitis, not specified as acute or chronic",25059,43,1.09 [0.75-1.59],0.6556130737256577
BID,BH3-interacting domain death agonist,Chapter X Diseases of the respiratory system,Chronic lower respiratory diseases,27435,2419,1.05 [1.00-1.11],0.0607317103678959
BID,BH3-interacting domain death agonist,Chapter X Diseases of the respiratory system,"Chronic rhinitis, nasopharyngitis and pharyngitis",26802,68,1.11 [0.82-1.50],0.4963906123129818
BID,BH3-interacting domain death agonist,Chapter X Diseases of the respiratory system,Chronic sinusitis,26905,171,1.30 [1.08-1.55],0.0045552622085144
BID,BH3-interacting domain death agonist,Chapter X Diseases of the respiratory system,"COPD, hospital admissions 1, only main diagnosis",28216,736,1.07 [0.97-1.17],0.1632032299027982
BID,BH3-interacting domain death agonist,Chapter X Diseases of the respiratory system,Deviated nasal septum,26866,132,0.98 [0.78-1.23],0.8572227077499868
BID,BH3-interacting domain death agonist,Chapter X Diseases of the respiratory system,Diseases of the respiratory system,26352,4364,1.06 [1.02-1.10],0.0042706260907887
BID,BH3-interacting domain death agonist,Chapter X Diseases of the respiratory system,"Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified",27124,390,1.03 [0.91-1.17],0.633708886755322
BID,BH3-interacting domain death agonist,Chapter X Diseases of the respiratory system,Early onset COPD,27995,515,1.06 [0.95-1.19],0.2738477553489281
BID,BH3-interacting domain death agonist,Chapter X Diseases of the respiratory system,Emphysema,25206,190,1.03 [0.85-1.24],0.760448591775957
BID,BH3-interacting domain death agonist,Chapter X Diseases of the respiratory system,Idiopathic pulmonary fibrosis,27057,119,0.93 [0.73-1.18],0.5573481184532553
BID,BH3-interacting domain death agonist,Chapter X Diseases of the respiratory system,Influenza and pneumonia,28138,1229,1.02 [0.95-1.10],0.6106701926877008
BID,BH3-interacting domain death agonist,Chapter X Diseases of the respiratory system,Interstitial lung disease,27082,144,0.95 [0.76-1.18],0.6419679959238879
BID,BH3-interacting domain death agonist,Chapter X Diseases of the respiratory system,Later onset COPD,26856,221,1.09 [0.92-1.29],0.3231805694096129
BID,BH3-interacting domain death agonist,Chapter X Diseases of the respiratory system,Lung diseases due to external agents,28315,155,0.96 [0.78-1.18],0.6944078078640141
BID,BH3-interacting domain death agonist,Chapter X Diseases of the respiratory system,Nasal polyp,26850,116,1.18 [0.94-1.48],0.148298122296156
BID,BH3-interacting domain death agonist,Chapter X Diseases of the respiratory system,Other acute lower respiratory infections,28108,631,1.10 [0.99-1.21],0.0628795613874715
BID,BH3-interacting domain death agonist,Chapter X Diseases of the respiratory system,Other diseases of pleura,28143,1275,1.13 [1.06-1.21],0.0004197512453438
BID,BH3-interacting domain death agonist,Chapter X Diseases of the respiratory system,Other diseases of upper respiratory tract,27646,912,1.12 [1.03-1.21],0.0076424229428101
BID,BH3-interacting domain death agonist,Chapter X Diseases of the respiratory system,Other pleural conditions,26901,33,0.97 [0.61-1.53],0.8854289328651415
BID,BH3-interacting domain death agonist,Chapter X Diseases of the respiratory system,Other respiratory diseases principally affecting the interstitium,28267,207,0.99 [0.83-1.19],0.9376401765184632
BID,BH3-interacting domain death agonist,Chapter X Diseases of the respiratory system,Other respiratory disorders and diseases,28238,869,1.13 [1.04-1.23],0.0039714121141519
BID,BH3-interacting domain death agonist,Chapter X Diseases of the respiratory system,Pleural effusion,27471,603,1.14 [1.03-1.26],0.0113176629990795
BID,BH3-interacting domain death agonist,Chapter X Diseases of the respiratory system,Pleural plaque,26926,58,1.12 [0.81-1.55],0.504416423515146
BID,BH3-interacting domain death agonist,Chapter X Diseases of the respiratory system,"Pneumonia, organism unspecified",27923,1014,1.01 [0.93-1.09],0.8295461069100192
BID,BH3-interacting domain death agonist,Chapter X Diseases of the respiratory system,Pneumonitis due to solids and liquids,28294,134,0.95 [0.76-1.19],0.6655201358721026
BID,BH3-interacting domain death agonist,Chapter X Diseases of the respiratory system,Pneumothorax,26933,65,1.33 [1.00-1.78],0.0526655053932356
BID,BH3-interacting domain death agonist,Chapter X Diseases of the respiratory system,Pollen allergy,28287,273,1.14 [0.98-1.32],0.0969945216946967
BID,BH3-interacting domain death agonist,Chapter X Diseases of the respiratory system,Pulmonary oedema,28099,39,0.97 [0.64-1.47],0.894545766614367
BID,BH3-interacting domain death agonist,Chapter X Diseases of the respiratory system,Respiratory insufficiency,20895,38,1.12 [0.76-1.66],0.5589184121365209
BID,BH3-interacting domain death agonist,Chapter X Diseases of the respiratory system,Unspecified acute lower respiratory infection,28090,613,1.08 [0.98-1.20],0.1207566115129802
BID,BH3-interacting domain death agonist,Chapter X Diseases of the respiratory system,Vasomotor and allergic rhinitis,27054,320,1.18 [1.03-1.36],0.0158330328255395
BID,BH3-interacting domain death agonist,Chapter X Diseases of the respiratory system,Viral pneumonia,27105,196,1.04 [0.87-1.25],0.6417421611976137
BID,BH3-interacting domain death agonist,Chapter X Diseases of the respiratory system,"Viral pneumonia (unknown virus, not influenza)",28050,168,1.01 [0.83-1.23],0.9522345753802504
BID,BH3-interacting domain death agonist,Chapter X Diseases of the respiratory system,Vocal cord dysfunction,16358,106,1.18 [0.93-1.50],0.164807810668261
BID,BH3-interacting domain death agonist,Chapter XI Diseases of the digestive system,Abscess of anal and rectal regions,21679,65,1.04 [0.76-1.42],0.8033978931607311
BID,BH3-interacting domain death agonist,Chapter XI Diseases of the digestive system,Acute appendicitis,28117,162,0.91 [0.74-1.12],0.3717553729459029
BID,BH3-interacting domain death agonist,Chapter XI Diseases of the digestive system,Acute gastritis,22629,76,1.14 [0.85-1.51],0.3822850520060544
BID,BH3-interacting domain death agonist,Chapter XI Diseases of the digestive system,Acute pancreatitis,26693,166,0.91 [0.74-1.12],0.3725376829984632
BID,BH3-interacting domain death agonist,Chapter XI Diseases of the digestive system,Acute peritonitis,27874,76,1.02 [0.76-1.37],0.8946898800601354
BID,BH3-interacting domain death agonist,Chapter XI Diseases of the digestive system,Alcoholic liver disease,27525,84,0.78 [0.58-1.05],0.0983738553534054
BID,BH3-interacting domain death agonist,Chapter XI Diseases of the digestive system,Barrett oesophagus,22913,360,0.95 [0.82-1.09],0.4567426760324705
BID,BH3-interacting domain death agonist,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC)",26583,56,0.96 [0.68-1.36],0.8205710726496576
BID,BH3-interacting domain death agonist,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC), with reimbursement 202",27907,56,0.96 [0.68-1.36],0.8141014079325396
BID,BH3-interacting domain death agonist,Chapter XI Diseases of the digestive system,Cholecystitis,26710,183,1.17 [0.98-1.41],0.0830416832644635
BID,BH3-interacting domain death agonist,Chapter XI Diseases of the digestive system,Cholelithiasis,27457,930,1.08 [0.99-1.17],0.0732450492907263
BID,BH3-interacting domain death agonist,Chapter XI Diseases of the digestive system,Chronic gastritis,22818,265,1.02 [0.87-1.20],0.807005240793043
BID,BH3-interacting domain death agonist,Chapter XI Diseases of the digestive system,Chronic pancreatitis,26568,41,0.82 [0.54-1.26],0.3642012818779961
BID,BH3-interacting domain death agonist,Chapter XI Diseases of the digestive system,"Cirrhosis of liver, NAS",28172,78,0.70 [0.51-0.96],0.0264456519853813
BID,BH3-interacting domain death agonist,Chapter XI Diseases of the digestive system,Coeliac disease,26854,119,0.90 [0.70-1.15],0.3823181314237813
BID,BH3-interacting domain death agonist,Chapter XI Diseases of the digestive system,Collagenous colitis,26722,61,1.18 [0.86-1.61],0.3011549600274818
BID,BH3-interacting domain death agonist,Chapter XI Diseases of the digestive system,Colonic or urogenital fistula,28135,212,1.06 [0.90-1.27],0.4792220589271331
BID,BH3-interacting domain death agonist,Chapter XI Diseases of the digestive system,Constipation,28096,1209,0.99 [0.92-1.06],0.7187372505429905
BID,BH3-interacting domain death agonist,Chapter XI Diseases of the digestive system,Crohn disease,26756,95,1.20 [0.93-1.53],0.1584578106390815
BID,BH3-interacting domain death agonist,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, all UC cases excluded)",27968,67,1.30 [0.97-1.73],0.0743978580738302
BID,BH3-interacting domain death agonist,Chapter XI Diseases of the digestive system,Crohn's disease NAS,26753,92,1.18 [0.92-1.52],0.199492155217963
BID,BH3-interacting domain death agonist,Chapter XI Diseases of the digestive system,Dental caries,27463,266,1.11 [0.96-1.29],0.1705423979312332
BID,BH3-interacting domain death agonist,Chapter XI Diseases of the digestive system,Diaphragmatic hernia,26190,1877,1.06 [1.00-1.13],0.0471025745259671
BID,BH3-interacting domain death agonist,Chapter XI Diseases of the digestive system,Diseases of appendix,28160,205,0.96 [0.80-1.16],0.6967482744680856
BID,BH3-interacting domain death agonist,Chapter XI Diseases of the digestive system,Diseases of liver,28203,762,1.02 [0.93-1.12],0.6040265486442817
BID,BH3-interacting domain death agonist,Chapter XI Diseases of the digestive system,"Diseases of oesophagus, stomach and duodenum",26566,4013,1.01 [0.97-1.06],0.5027896674748058
BID,BH3-interacting domain death agonist,Chapter XI Diseases of the digestive system,"Diseases of oral cavity, salivary glands and jaws",27827,630,1.10 [0.99-1.21],0.0633506753695795
BID,BH3-interacting domain death agonist,Chapter XI Diseases of the digestive system,Diseases of peritoneum,28240,442,1.09 [0.96-1.22],0.1724781100698416
BID,BH3-interacting domain death agonist,Chapter XI Diseases of the digestive system,Diseases of pulp and periapical tissues,27330,133,1.07 [0.86-1.33],0.5682286806292378
BID,BH3-interacting domain death agonist,Chapter XI Diseases of the digestive system,Diseases of salivary glands,27165,71,0.96 [0.70-1.31],0.7946650381478177
BID,BH3-interacting domain death agonist,Chapter XI Diseases of the digestive system,Diseases of the digestive system,28038,1303,1.07 [1.00-1.15],0.05029475082319
BID,BH3-interacting domain death agonist,Chapter XI Diseases of the digestive system,Diseases of tongue,27179,120,0.97 [0.76-1.23],0.80512650553427
BID,BH3-interacting domain death agonist,Chapter XI Diseases of the digestive system,"Disorders of gallbladder, biliary tract and pancreas",27793,1266,1.08 [1.00-1.16],0.04179543058089
BID,BH3-interacting domain death agonist,Chapter XI Diseases of the digestive system,Diverticular disease of intestine,24115,2501,1.02 [0.97-1.08],0.3813282159079071
BID,BH3-interacting domain death agonist,Chapter XI Diseases of the digestive system,Duodenal ulcer,22699,146,0.95 [0.77-1.18],0.6607046793752716
BID,BH3-interacting domain death agonist,Chapter XI Diseases of the digestive system,"Duodenal ulcer - Unspecified as acute or chronic, without haemorrhage or perforation, drug-induced",28252,116,1.02 [0.80-1.29],0.8843358616743014
BID,BH3-interacting domain death agonist,Chapter XI Diseases of the digestive system,Embedded and impacted teeth,28184,83,1.19 [0.91-1.56],0.204054603632971
BID,BH3-interacting domain death agonist,Chapter XI Diseases of the digestive system,Fibrosis and cirrhosis of liver,27543,102,0.73 [0.55-0.96],0.0245858402846321
BID,BH3-interacting domain death agonist,Chapter XI Diseases of the digestive system,Fissure and fistula of anal and rectal regions,21800,186,1.01 [0.83-1.21],0.9514229226350304
BID,BH3-interacting domain death agonist,Chapter XI Diseases of the digestive system,Functional dyspepsia,23076,523,0.94 [0.84-1.06],0.3188659865285118
BID,BH3-interacting domain death agonist,Chapter XI Diseases of the digestive system,Gastric ulcer,22842,289,1.06 [0.92-1.23],0.4214773352394054
BID,BH3-interacting domain death agonist,Chapter XI Diseases of the digestive system,Gastro-oesophageal reflux disease,24870,2317,1.05 [0.99-1.11],0.0835063355774787
BID,BH3-interacting domain death agonist,Chapter XI Diseases of the digestive system,Gastroduodenal ulcer,22969,416,1.01 [0.89-1.15],0.8673682991919512
BID,BH3-interacting domain death agonist,Chapter XI Diseases of the digestive system,Gastrointestinal diseases,23137,8294,1.02 [1.00-1.05],0.0939079292484761
BID,BH3-interacting domain death agonist,Chapter XI Diseases of the digestive system,GI-bleeding,27786,1051,1.06 [0.98-1.15],0.1198082850888403
BID,BH3-interacting domain death agonist,Chapter XI Diseases of the digestive system,Gingivitis and periodontal diseases,27258,61,1.08 [0.78-1.49],0.6512177246745913
BID,BH3-interacting domain death agonist,Chapter XI Diseases of the digestive system,Haemorrhoids and perianal venous thrombosis,22562,1321,1.07 [1.00-1.15],0.0643398844382081
BID,BH3-interacting domain death agonist,Chapter XI Diseases of the digestive system,"Hepatic failure, not elsewhere classified",27496,55,0.94 [0.66-1.33],0.7140321650193528
BID,BH3-interacting domain death agonist,Chapter XI Diseases of the digestive system,Hernia,27133,2820,1.04 [0.99-1.09],0.1636073977319338
BID,BH3-interacting domain death agonist,Chapter XI Diseases of the digestive system,Impacted teeth,28194,77,1.27 [0.97-1.66],0.0876756370533797
BID,BH3-interacting domain death agonist,Chapter XI Diseases of the digestive system,Impaction of intestines,21648,34,1.33 [0.89-1.98],0.1647364425333177
BID,BH3-interacting domain death agonist,Chapter XI Diseases of the digestive system,Inguinal hernia,25010,697,1.02 [0.93-1.13],0.6480447736293498
BID,BH3-interacting domain death agonist,Chapter XI Diseases of the digestive system,"Inguinal hernia, bilateral",24393,80,0.94 [0.69-1.27],0.6670218034884698
BID,BH3-interacting domain death agonist,Chapter XI Diseases of the digestive system,Intestinal adhesions without obstruction,21691,77,0.92 [0.68-1.25],0.6093076695715989
BID,BH3-interacting domain death agonist,Chapter XI Diseases of the digestive system,Intestinal malabsorption,26873,138,0.99 [0.79-1.23],0.9021194023196224
BID,BH3-interacting domain death agonist,Chapter XI Diseases of the digestive system,Irritable bowel syndrome,22203,589,1.09 [0.98-1.21],0.107986804130529
BID,BH3-interacting domain death agonist,Chapter XI Diseases of the digestive system,Nonalcoholic fatty liver disease,28296,400,1.15 [1.02-1.30],0.0203853425917497
BID,BH3-interacting domain death agonist,Chapter XI Diseases of the digestive system,Noninfectious colitis NAS,27380,719,1.05 [0.96-1.16],0.3008003256426612
BID,BH3-interacting domain death agonist,Chapter XI Diseases of the digestive system,Noninfective enteritis and colitis,27568,907,1.08 [0.99-1.17],0.0809049748821604
BID,BH3-interacting domain death agonist,Chapter XI Diseases of the digestive system,Oesophageal obstruction,22708,155,1.20 [0.98-1.46],0.0714580835234435
BID,BH3-interacting domain death agonist,Chapter XI Diseases of the digestive system,Oesophagitis,23053,500,1.11 [1.00-1.25],0.0590709615070579
BID,BH3-interacting domain death agonist,Chapter XI Diseases of the digestive system,Oral lichen ruber planus,28279,139,1.00 [0.80-1.24],0.9667017910962368
BID,BH3-interacting domain death agonist,Chapter XI Diseases of the digestive system,Other and unspecified abdominal hernia,24365,52,1.03 [0.72-1.48],0.8511107065103206
BID,BH3-interacting domain death agonist,Chapter XI Diseases of the digestive system,Other diseases of anus and rectum,22946,1332,1.06 [0.99-1.14],0.0983845516515984
BID,BH3-interacting domain death agonist,Chapter XI Diseases of the digestive system,Other diseases of biliary tract,26728,201,1.06 [0.88-1.27],0.5338398808014486
BID,BH3-interacting domain death agonist,Chapter XI Diseases of the digestive system,Other diseases of gallbladder,26692,165,1.09 [0.90-1.33],0.3900547950281694
BID,BH3-interacting domain death agonist,Chapter XI Diseases of the digestive system,Other diseases of intestine,23155,1541,1.02 [0.96-1.09],0.5253244720673726
BID,BH3-interacting domain death agonist,Chapter XI Diseases of the digestive system,Other diseases of intestines,26636,5022,1.03 [0.99-1.06],0.1659359699406454
BID,BH3-interacting domain death agonist,Chapter XI Diseases of the digestive system,Other diseases of lip and oral mucosa,27172,206,0.97 [0.81-1.16],0.7285334695712993
BID,BH3-interacting domain death agonist,Chapter XI Diseases of the digestive system,Other diseases of liver,28057,616,1.02 [0.92-1.14],0.6426254059348426
BID,BH3-interacting domain death agonist,Chapter XI Diseases of the digestive system,Other diseases of oesophagus,23104,551,1.00 [0.90-1.12],0.9919803732551716
BID,BH3-interacting domain death agonist,Chapter XI Diseases of the digestive system,Other diseases of pancreas,26612,85,1.02 [0.77-1.36],0.8697825132163679
BID,BH3-interacting domain death agonist,Chapter XI Diseases of the digestive system,Other diseases of peritoneum,28181,383,1.09 [0.96-1.24],0.2010048070376314
BID,BH3-interacting domain death agonist,Chapter XI Diseases of the digestive system,Other diseases of stomach and duodenum,23355,802,0.98 [0.89-1.07],0.666521353960245
BID,BH3-interacting domain death agonist,Chapter XI Diseases of the digestive system,Other diseases of the digestive system,27800,1065,1.07 [0.99-1.16],0.0926127445618625
BID,BH3-interacting domain death agonist,Chapter XI Diseases of the digestive system,Other disorders of teeth and supporting structures,27392,195,1.09 [0.91-1.30],0.3564240747573934
BID,BH3-interacting domain death agonist,Chapter XI Diseases of the digestive system,Other functional intestinal disorders,22871,1257,1.00 [0.93-1.07],0.9680981106853076
BID,BH3-interacting domain death agonist,Chapter XI Diseases of the digestive system,Other gastritis (incl. Duodenitis),24376,1823,0.99 [0.94-1.06],0.8436782665190272
BID,BH3-interacting domain death agonist,Chapter XI Diseases of the digestive system,Other inflammatory liver diseases,27525,84,0.97 [0.73-1.29],0.8254647939325801
BID,BH3-interacting domain death agonist,Chapter XI Diseases of the digestive system,Other noninfective gastroenteritis and colitis,27455,794,1.04 [0.95-1.14],0.4106774261305067
BID,BH3-interacting domain death agonist,Chapter XI Diseases of the digestive system,"Other or unspecified ileus, impaction or obstruction",21850,236,1.24 [1.06-1.45],0.0065748157254707
BID,BH3-interacting domain death agonist,Chapter XI Diseases of the digestive system,Palatinal maxillary canine,28168,97,1.16 [0.90-1.49],0.2495315679849988
BID,BH3-interacting domain death agonist,Chapter XI Diseases of the digestive system,Paralytic ileus and intestinal obstruction,21972,358,1.10 [0.96-1.25],0.1710395545737308
BID,BH3-interacting domain death agonist,Chapter XI Diseases of the digestive system,"Postprocedural disorders of digestive system, not elsewhere classified",26876,141,1.21 [0.99-1.49],0.0676167111748815
BID,BH3-interacting domain death agonist,Chapter XI Diseases of the digestive system,Recurring oral aphthae,28313,60,0.78 [0.55-1.11],0.1649872134294465
BID,BH3-interacting domain death agonist,Chapter XI Diseases of the digestive system,Stomatitis and related lesions,27213,131,0.85 [0.67-1.08],0.1895581682411781
BID,BH3-interacting domain death agonist,Chapter XI Diseases of the digestive system,Toxic colitis,26694,33,0.86 [0.54-1.37],0.5302109872380483
BID,BH3-interacting domain death agonist,Chapter XI Diseases of the digestive system,Ulcer of oesophagus,22741,188,1.19 [0.99-1.42],0.0585845323256471
BID,BH3-interacting domain death agonist,Chapter XI Diseases of the digestive system,Ulcerative colitis,26813,152,1.36 [1.13-1.64],0.001190095722283
BID,BH3-interacting domain death agonist,Chapter XI Diseases of the digestive system,"Ulcerative colitis, NAS",26793,132,1.43 [1.18-1.74],0.0002859888837275
BID,BH3-interacting domain death agonist,Chapter XI Diseases of the digestive system,Umbilical hernia,24600,287,0.94 [0.81-1.10],0.4724153211413505
BID,BH3-interacting domain death agonist,Chapter XI Diseases of the digestive system,Vascular disorders of the intestines,21718,104,1.01 [0.78-1.30],0.9482526297679128
BID,BH3-interacting domain death agonist,Chapter XI Diseases of the digestive system,Ventral hernia,24543,230,1.00 [0.85-1.19],0.9687202095056786
BID,BH3-interacting domain death agonist,Chapter XI Diseases of the digestive system,Volvulus,21680,66,0.97 [0.70-1.34],0.8637462042618518
BID,BH3-interacting domain death agonist,Chapter XII Diseases of the skin and subcutaneous tissue,Actinic keratosis,28264,163,0.90 [0.73-1.11],0.3327859163489691
BID,BH3-interacting domain death agonist,Chapter XII Diseases of the skin and subcutaneous tissue,Arthropathic psoriasis,28043,79,1.15 [0.87-1.52],0.3253215674119148
BID,BH3-interacting domain death agonist,Chapter XII Diseases of the skin and subcutaneous tissue,Atrophic disorders of skin,26811,148,1.08 [0.87-1.32],0.4946482015573227
BID,BH3-interacting domain death agonist,Chapter XII Diseases of the skin and subcutaneous tissue,Cellulitis,27683,570,1.06 [0.95-1.17],0.3111995249971005
BID,BH3-interacting domain death agonist,Chapter XII Diseases of the skin and subcutaneous tissue,"Cutaneous abscess, furuncle and carbuncle",27316,203,1.00 [0.84-1.20],0.9833583335221016
BID,BH3-interacting domain death agonist,Chapter XII Diseases of the skin and subcutaneous tissue,Decubitus ulcer and pressure area,26842,179,1.04 [0.86-1.26],0.6785459948670877
BID,BH3-interacting domain death agonist,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis,28052,233,1.14 [0.97-1.34],0.1130069796907036
BID,BH3-interacting domain death agonist,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis and eczema,28221,402,1.05 [0.92-1.19],0.4864416898354329
BID,BH3-interacting domain death agonist,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis due to substances taken internally,27867,48,0.98 [0.68-1.42],0.920514284289011
BID,BH3-interacting domain death agonist,Chapter XII Diseases of the skin and subcutaneous tissue,Diseases of the skin and subcutaneous tissue,26812,2635,1.02 [0.97-1.07],0.4348542362817132
BID,BH3-interacting domain death agonist,Chapter XII Diseases of the skin and subcutaneous tissue,Disorders of skin appendages,27854,456,0.94 [0.83-1.06],0.2972965872628924
BID,BH3-interacting domain death agonist,Chapter XII Diseases of the skin and subcutaneous tissue,Follicular cysts of skin and subcutaneous tissue,27725,327,0.92 [0.80-1.07],0.2917034407481886
BID,BH3-interacting domain death agonist,Chapter XII Diseases of the skin and subcutaneous tissue,Infections of the skin and subcutaneous tissue,27923,810,1.07 [0.98-1.16],0.1580804541214843
BID,BH3-interacting domain death agonist,Chapter XII Diseases of the skin and subcutaneous tissue,"Lichen planus, including avohilmo",28309,49,1.36 [0.98-1.90],0.067736618085679
BID,BH3-interacting domain death agonist,Chapter XII Diseases of the skin and subcutaneous tissue,Lupus erythematosus,26717,54,0.82 [0.56-1.18],0.2791338766462962
BID,BH3-interacting domain death agonist,Chapter XII Diseases of the skin and subcutaneous tissue,Nail disorders,27440,42,1.22 [0.84-1.76],0.293669216767813
BID,BH3-interacting domain death agonist,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified dermatitis,28046,227,1.11 [0.94-1.31],0.2202340405904718
BID,BH3-interacting domain death agonist,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified disorders of skin and subcutaneous tissue,26957,294,1.10 [0.95-1.27],0.2152778239058282
BID,BH3-interacting domain death agonist,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified epidermal thickening,26700,37,1.26 [0.85-1.87],0.2509858487733344
BID,BH3-interacting domain death agonist,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified erythematous conditions,28241,69,1.13 [0.84-1.52],0.423421272967133
BID,BH3-interacting domain death agonist,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified local infections of skin and subcutaneous tissue,27252,139,1.26 [1.03-1.53],0.0237531744825346
BID,BH3-interacting domain death agonist,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified psoriasis,28122,158,0.84 [0.68-1.04],0.1047585320038251
BID,BH3-interacting domain death agonist,Chapter XII Diseases of the skin and subcutaneous tissue,Other contact dermatitis,27852,33,0.78 [0.49-1.26],0.3112654163210246
BID,BH3-interacting domain death agonist,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of pigmentation,26718,55,0.94 [0.66-1.34],0.7256055401389194
BID,BH3-interacting domain death agonist,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of skin and subcutaneous tissue,27783,1120,1.03 [0.95-1.11],0.4508676779712405
BID,BH3-interacting domain death agonist,Chapter XII Diseases of the skin and subcutaneous tissue,"Other disorders of skin and subcutaneous tissue, not elsewhere classified",26987,324,1.14 [0.99-1.31],0.0679546986970866
BID,BH3-interacting domain death agonist,Chapter XII Diseases of the skin and subcutaneous tissue,Other epidermal thickening,26704,41,1.31 [0.91-1.89],0.1504179010058572
BID,BH3-interacting domain death agonist,Chapter XII Diseases of the skin and subcutaneous tissue,Papulosquamous disorders,28236,272,1.04 [0.89-1.21],0.6576020068532655
BID,BH3-interacting domain death agonist,Chapter XII Diseases of the skin and subcutaneous tissue,Pruritus,27883,64,0.81 [0.58-1.13],0.2182496836372682
BID,BH3-interacting domain death agonist,Chapter XII Diseases of the skin and subcutaneous tissue,Psoriasis,28186,222,0.98 [0.82-1.16],0.7837576392576913
BID,BH3-interacting domain death agonist,Chapter XII Diseases of the skin and subcutaneous tissue,Radiation-related disorders of the skin and subcutaneous tissue,28288,187,0.90 [0.74-1.10],0.2995189977499539
BID,BH3-interacting domain death agonist,Chapter XII Diseases of the skin and subcutaneous tissue,Scar conditions and fibrosis of skin,26785,122,1.09 [0.86-1.37],0.4733430118427801
BID,BH3-interacting domain death agonist,Chapter XII Diseases of the skin and subcutaneous tissue,Seborrhoeic keratosis,26860,197,0.91 [0.75-1.10],0.3084612991044195
BID,BH3-interacting domain death agonist,Chapter XII Diseases of the skin and subcutaneous tissue,Skin changes due to chronic exposure to nonionizing radiation,28278,177,0.92 [0.75-1.13],0.4240119128019959
BID,BH3-interacting domain death agonist,Chapter XII Diseases of the skin and subcutaneous tissue,"Ulcer of lower limb, not elsewhere classified",26796,133,1.17 [0.95-1.43],0.1472843140085009
BID,BH3-interacting domain death agonist,Chapter XII Diseases of the skin and subcutaneous tissue,Urticaria and erythema,28289,117,1.11 [0.88-1.40],0.3632752674275459
BID,BH3-interacting domain death agonist,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Adhesive capsulitis of shoulder,24869,139,1.21 [0.99-1.49],0.0635878214346471
BID,BH3-interacting domain death agonist,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthropathies,26460,4773,1.01 [0.97-1.05],0.5849679333931694
BID,BH3-interacting domain death agonist,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthrosis,25059,3372,1.01 [0.96-1.05],0.7464663759197796
BID,BH3-interacting domain death agonist,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Bursitis of shoulder,24826,96,1.02 [0.79-1.33],0.8631654216727036
BID,BH3-interacting domain death agonist,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervical disc disorders,25426,155,1.07 [0.87-1.31],0.5259444113367099
BID,BH3-interacting domain death agonist,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervicalgia,25437,166,1.12 [0.92-1.36],0.2611159283569251
BID,BH3-interacting domain death agonist,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Chondropathies,28087,118,0.98 [0.78-1.25],0.8963743210889623
BID,BH3-interacting domain death agonist,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Collapsed vertebra, not elsewhere classified",25317,46,0.93 [0.63-1.38],0.7191986637634269
BID,BH3-interacting domain death agonist,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Coxarthrosis,22459,772,0.98 [0.89-1.08],0.6740745722338497
BID,BH3-interacting domain death agonist,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Coxarthrosis, primary",28267,129,1.19 [0.95-1.47],0.125078264126673
BID,BH3-interacting domain death agonist,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Deforming dorsopathies,25572,301,0.96 [0.83-1.12],0.6189094712540478
BID,BH3-interacting domain death agonist,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Diseases of the musculoskeletal system and connective tissue,24791,6411,1.02 [0.99-1.05],0.2889654240209379
BID,BH3-interacting domain death agonist,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of continuity of bone,26918,111,0.95 [0.74-1.22],0.7083498476910359
BID,BH3-interacting domain death agonist,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of muscles,24847,117,0.81 [0.63-1.04],0.0972653729828499
BID,BH3-interacting domain death agonist,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of synovium and tendon,25354,624,1.01 [0.91-1.12],0.8374790943447707
BID,BH3-interacting domain death agonist,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Dorsopathies,27418,2147,1.05 [0.99-1.11],0.1005019579862776
BID,BH3-interacting domain death agonist,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibroblastic disorders,24958,228,1.13 [0.96-1.34],0.137406771292097
BID,BH3-interacting domain death agonist,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibromyalgia,25021,291,1.19 [1.03-1.37],0.0178870689226788
BID,BH3-interacting domain death agonist,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Ganglion,24883,153,1.06 [0.86-1.30],0.5935454562251988
BID,BH3-interacting domain death agonist,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Giant cell arteritis,27799,38,1.25 [0.85-1.85],0.2624496235662612
BID,BH3-interacting domain death agonist,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gonarthrosis,23036,1349,1.02 [0.95-1.09],0.6239654271318971
BID,BH3-interacting domain death agonist,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gout,22094,407,1.10 [0.97-1.25],0.12116677253867
BID,BH3-interacting domain death agonist,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Gout, unspecified",28269,397,1.13 [0.99-1.28],0.0646285887290207
BID,BH3-interacting domain death agonist,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux rigidus,21759,72,0.93 [0.68-1.27],0.6428776129135991
BID,BH3-interacting domain death agonist,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux valgus (acquired),22039,352,0.89 [0.77-1.03],0.1254235077778552
BID,BH3-interacting domain death agonist,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Impingement syndrome of shoulder,25069,339,0.97 [0.84-1.12],0.6682121227540407
BID,BH3-interacting domain death agonist,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Internal derangement of knee,22474,787,1.03 [0.94-1.13],0.4769710521757438
BID,BH3-interacting domain death agonist,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Kyphosis,25300,29,0.70 [0.41-1.17],0.1749411655509431
BID,BH3-interacting domain death agonist,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Low back pain,25841,570,1.06 [0.95-1.18],0.2720905386131383
BID,BH3-interacting domain death agonist,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Lumbar disc prolapse,25557,286,1.12 [0.97-1.30],0.122320429083873
BID,BH3-interacting domain death agonist,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Meniscus derangement,22420,733,1.02 [0.93-1.12],0.6948793625200673
BID,BH3-interacting domain death agonist,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Myalgia,24817,87,1.22 [0.94-1.58],0.1269243910012677
BID,BH3-interacting domain death agonist,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Neuralgia and neuritis, unspecified",24793,63,1.06 [0.77-1.46],0.7260770067470816
BID,BH3-interacting domain death agonist,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteomyelitis,26866,59,1.29 [0.97-1.73],0.0837029094730546
BID,BH3-interacting domain death agonist,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteopathies and chondropathies,27979,1172,0.99 [0.91-1.07],0.7392343771214143
BID,BH3-interacting domain death agonist,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteoporosis,27468,661,0.99 [0.90-1.10],0.8952508788351032
BID,BH3-interacting domain death agonist,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other (seronegative) rheumatoid arthritis, wide",28212,352,0.98 [0.85-1.12],0.7719695469106282
BID,BH3-interacting domain death agonist,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other arthrosis,23502,1815,1.01 [0.95-1.07],0.8232169028191997
BID,BH3-interacting domain death agonist,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other articular cartilage disorders,21769,82,1.01 [0.76-1.35],0.9471717468945596
BID,BH3-interacting domain death agonist,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other bursopathies,24809,79,1.05 [0.79-1.40],0.722906887600161
BID,BH3-interacting domain death agonist,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other crystal arthropathies,21715,28,0.82 [0.49-1.38],0.4655792238640527
BID,BH3-interacting domain death agonist,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other deformities of toe(s),21798,111,0.85 [0.65-1.09],0.2033373626928437
BID,BH3-interacting domain death agonist,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone,27043,236,0.93 [0.78-1.10],0.3936406968955258
BID,BH3-interacting domain death agonist,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone density and structure,27055,248,1.04 [0.88-1.22],0.6695585020262136
BID,BH3-interacting domain death agonist,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of the musculoskeletal system and connective tissue,28281,83,0.88 [0.66-1.18],0.3944554723657281
BID,BH3-interacting domain death agonist,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other dorsopathies, not elsewhere classified",26876,1605,1.07 [1.01-1.14],0.0302726305984983
BID,BH3-interacting domain death agonist,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other enthesopathies,24852,122,0.95 [0.75-1.20],0.6639054327737999
BID,BH3-interacting domain death agonist,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other hammer toe(s) (acquired),21805,118,0.79 [0.62-1.02],0.0750910420218323
BID,BH3-interacting domain death agonist,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other intervertebral disc disorders,25918,647,1.04 [0.94-1.15],0.4345475502912027
BID,BH3-interacting domain death agonist,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other joint disorders,23776,2089,1.00 [0.95-1.06],0.9749489267114764
BID,BH3-interacting domain death agonist,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other necrotizing vasculopathies,27822,61,1.18 [0.86-1.61],0.3141682786664993
BID,BH3-interacting domain death agonist,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other psoriatic arthropathies,28297,75,1.21 [0.92-1.60],0.1802301785286151
BID,BH3-interacting domain death agonist,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other shoulder lesions,24815,85,1.13 [0.86-1.48],0.3914474440960264
BID,BH3-interacting domain death agonist,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other soft tissue disorders, not elsewhere classified",25857,1127,1.05 [0.97-1.13],0.2066431965525753
BID,BH3-interacting domain death agonist,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified disorders of muscle,24800,70,0.89 [0.64-1.22],0.4606261208765405
BID,BH3-interacting domain death agonist,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified arthritis,22835,1148,1.06 [0.98-1.14],0.1552883802348071
BID,BH3-interacting domain death agonist,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of  bone/cartilage,26911,104,0.88 [0.68-1.14],0.322658177341332
BID,BH3-interacting domain death agonist,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies,24800,70,1.05 [0.78-1.43],0.7342797638660097
BID,BH3-interacting domain death agonist,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified inflammatory spondylopathies,25388,117,1.14 [0.91-1.44],0.2515135822068857
BID,BH3-interacting domain death agonist,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified soft tissue disorders,25144,414,0.97 [0.85-1.10],0.5890768570806859
BID,BH3-interacting domain death agonist,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other systemic involvement of connective tissue,27976,215,1.02 [0.85-1.21],0.8383643931612121
BID,BH3-interacting domain death agonist,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified dorsalgia,25748,477,1.06 [0.94-1.19],0.3255796524893522
BID,BH3-interacting domain death agonist,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified rheumatoid arthritis,28221,332,0.99 [0.86-1.14],0.8671923723950291
BID,BH3-interacting domain death agonist,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified seropositive rheumatoid arthritis,28306,38,0.74 [0.47-1.16],0.1906496263211591
BID,BH3-interacting domain death agonist,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified synovitis and tenosynovitis,24940,210,1.20 [1.01-1.42],0.0345107787270632
BID,BH3-interacting domain death agonist,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in joint,22738,616,1.00 [0.90-1.11],0.968338900150857
BID,BH3-interacting domain death agonist,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in limb,25243,513,1.01 [0.91-1.14],0.799388754961244
BID,BH3-interacting domain death agonist,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Palmar fascial fibromatosis [Dupuytren],24902,172,1.13 [0.93-1.37],0.2114852429683238
BID,BH3-interacting domain death agonist,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Polyarthritis, unspecified",21724,37,0.69 [0.43-1.08],0.1048910837267745
BID,BH3-interacting domain death agonist,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthropathies,23500,1813,1.03 [0.97-1.10],0.3032005349092245
BID,BH3-interacting domain death agonist,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthrosis,22152,465,0.94 [0.83-1.07],0.3455081925880483
BID,BH3-interacting domain death agonist,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polymyalgia rheumatica,27850,89,1.18 [0.90-1.53],0.2268556527891254
BID,BH3-interacting domain death agonist,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Postprocedural musculoskeletal disorders, not elsewhere classified",28247,49,0.76 [0.51-1.12],0.1635738707893183
BID,BH3-interacting domain death agonist,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Primary gonarthrosis, bilateral",26678,29,1.19 [0.75-1.90],0.4593057294075505
BID,BH3-interacting domain death agonist,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Psoriatic arthropathies,21764,77,1.17 [0.89-1.55],0.263929529739081
BID,BH3-interacting domain death agonist,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Radiculopathy,25362,91,1.03 [0.79-1.35],0.8282313794480453
BID,BH3-interacting domain death agonist,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rheumatoid arthritis,22043,356,0.98 [0.86-1.13],0.8122287288086447
BID,BH3-interacting domain death agonist,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rotator cuff syndrome,25005,275,0.90 [0.76-1.05],0.1895823923253677
BID,BH3-interacting domain death agonist,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sciatica+with lumbago,25487,216,1.17 [0.99-1.38],0.0634987961174492
BID,BH3-interacting domain death agonist,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Scoliosis,25380,109,0.90 [0.70-1.16],0.4276532386494623
BID,BH3-interacting domain death agonist,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Seronegative rheumatoid arthritis,24011,50,1.12 [0.79-1.60],0.5132125210613347
BID,BH3-interacting domain death agonist,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Seropositive rheumatoid arthritis, wide",28309,41,0.70 [0.45-1.08],0.1103337112969968
BID,BH3-interacting domain death agonist,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Shoulder lesions,25352,622,1.00 [0.91-1.11],0.9265304506530296
BID,BH3-interacting domain death agonist,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sicca syndrome [Sjgren],27850,89,0.84 [0.63-1.12],0.2283453731931602
BID,BH3-interacting domain death agonist,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Soft tissue disorders,27208,2478,1.02 [0.97-1.08],0.4021530802866273
BID,BH3-interacting domain death agonist,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Soft tissue disorders related to use, overuse and pressure",24840,110,0.93 [0.73-1.20],0.5930542141757826
BID,BH3-interacting domain death agonist,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spinal stenosis,25635,364,0.93 [0.81-1.07],0.3275334058353535
BID,BH3-interacting domain death agonist,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondyloarthritis,26901,188,1.10 [0.91-1.32],0.3237190312358464
BID,BH3-interacting domain death agonist,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylolisthesis/Spondylolysis,25427,156,0.95 [0.77-1.17],0.6144228925694873
BID,BH3-interacting domain death agonist,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylopathies,26353,1082,1.02 [0.95-1.11],0.5553453390956207
BID,BH3-interacting domain death agonist,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylosis,25991,720,1.02 [0.93-1.12],0.7151087439148086
BID,BH3-interacting domain death agonist,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Synovial cyst of popliteal space [Baker],24776,46,1.02 [0.70-1.49],0.911308436697042
BID,BH3-interacting domain death agonist,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Systemic lupus erythematosus,27902,141,0.85 [0.68-1.07],0.1732757912482309
BID,BH3-interacting domain death agonist,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trigger finger,24892,162,0.80 [0.64-0.99],0.0393171648845096
BID,BH3-interacting domain death agonist,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trochanteric bursitis,24789,59,0.77 [0.54-1.09],0.1408480011072587
BID,BH3-interacting domain death agonist,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Wrist or foot drop (acquired),21725,38,1.14 [0.76-1.69],0.5271202220150408
BID,BH3-interacting domain death agonist,Chapter XIV Diseases of the genitourinary system,Acute renal failure,27746,877,1.09 [1.00-1.18],0.0558980203793195
BID,BH3-interacting domain death agonist,Chapter XIV Diseases of the genitourinary system,Adenomyosis (Endometriosis of uterus),11510,79,1.09 [0.82-1.44],0.5735310460659151
BID,BH3-interacting domain death agonist,Chapter XIV Diseases of the genitourinary system,Benign mammary dysplasia,15286,78,0.82 [0.61-1.11],0.2060064511694344
BID,BH3-interacting domain death agonist,Chapter XIV Diseases of the genitourinary system,Calculus of kidney and ureter,28012,333,1.06 [0.93-1.22],0.3867878084180386
BID,BH3-interacting domain death agonist,Chapter XIV Diseases of the genitourinary system,Calculus of lower urinary tract,27741,62,0.73 [0.51-1.04],0.0852332345920534
BID,BH3-interacting domain death agonist,Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,27579,710,0.96 [0.87-1.06],0.44643514461006
BID,BH3-interacting domain death agonist,Chapter XIV Diseases of the genitourinary system,Chronic nephritic syndrome,28129,33,0.81 [0.50-1.31],0.3885686555138693
BID,BH3-interacting domain death agonist,Chapter XIV Diseases of the genitourinary system,Cyst of kidney,28140,192,1.00 [0.83-1.21],0.986971888534989
BID,BH3-interacting domain death agonist,Chapter XIV Diseases of the genitourinary system,Cystitis,26054,165,1.06 [0.87-1.29],0.5769195624726432
BID,BH3-interacting domain death agonist,Chapter XIV Diseases of the genitourinary system,Dialysis,26933,64,1.24 [0.92-1.67],0.157521157303766
BID,BH3-interacting domain death agonist,Chapter XIV Diseases of the genitourinary system,Diseases of male genital organs,12237,1167,1.02 [0.94-1.10],0.6934037882822186
BID,BH3-interacting domain death agonist,Chapter XIV Diseases of the genitourinary system,Disorders of breast,15415,207,0.86 [0.72-1.04],0.1176983867583882
BID,BH3-interacting domain death agonist,Chapter XIV Diseases of the genitourinary system,Endometriosis,11577,146,1.05 [0.85-1.30],0.6319985294972126
BID,BH3-interacting domain death agonist,Chapter XIV Diseases of the genitourinary system,"Excessive, frequent and irregular menstruation",11822,391,0.91 [0.79-1.04],0.1514121249395048
BID,BH3-interacting domain death agonist,Chapter XIV Diseases of the genitourinary system,Female genital prolapse,11865,434,1.11 [0.99-1.25],0.0859346129439163
BID,BH3-interacting domain death agonist,Chapter XIV Diseases of the genitourinary system,Genitourinary diseases,23876,4379,1.02 [0.98-1.06],0.2365229204367722
BID,BH3-interacting domain death agonist,Chapter XIV Diseases of the genitourinary system,Glomerular disorders in diseases classified elsewhere,28164,68,0.94 [0.69-1.30],0.7224574441718457
BID,BH3-interacting domain death agonist,Chapter XIV Diseases of the genitourinary system,Hydrocele,11160,90,0.91 [0.68-1.21],0.5066506150688717
BID,BH3-interacting domain death agonist,Chapter XIV Diseases of the genitourinary system,Hydronephrosis,26777,232,1.13 [0.96-1.33],0.1526627334807457
BID,BH3-interacting domain death agonist,Chapter XIV Diseases of the genitourinary system,Hyperplasia of prostate,11842,772,1.04 [0.94-1.14],0.4596279071432092
BID,BH3-interacting domain death agonist,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of female pelvic organs,15268,241,0.99 [0.84-1.17],0.9514424030292444
BID,BH3-interacting domain death agonist,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of prostate (prostatitis),11176,106,0.91 [0.70-1.18],0.477885956352525
BID,BH3-interacting domain death agonist,Chapter XIV Diseases of the genitourinary system,Irregular menses,15279,125,0.88 [0.69-1.11],0.2731323000575293
BID,BH3-interacting domain death agonist,Chapter XIV Diseases of the genitourinary system,Menorrhagia,11734,303,0.96 [0.83-1.12],0.6097744901770596
BID,BH3-interacting domain death agonist,Chapter XIV Diseases of the genitourinary system,Neuromuscular dysfunction of bladder,25959,70,0.97 [0.71-1.33],0.8696257372320403
BID,BH3-interacting domain death agonist,Chapter XIV Diseases of the genitourinary system,Noninflammatory disorders of female genital tract,12872,1441,1.03 [0.96-1.10],0.4544619851398525
BID,BH3-interacting domain death agonist,Chapter XIV Diseases of the genitourinary system,Orchitis and epididymitis,11119,49,0.96 [0.66-1.40],0.8270957646865948
BID,BH3-interacting domain death agonist,Chapter XIV Diseases of the genitourinary system,Other abnormal uterine and vaginal bleeding,11534,103,1.05 [0.82-1.35],0.6845895165646778
BID,BH3-interacting domain death agonist,Chapter XIV Diseases of the genitourinary system,"Other chronic cystitis, drug-induced",28311,39,1.20 [0.81-1.77],0.3630908414715786
BID,BH3-interacting domain death agonist,Chapter XIV Diseases of the genitourinary system,"Other cystitis, drug-induced",28318,48,1.06 [0.74-1.53],0.7445011099425609
BID,BH3-interacting domain death agonist,Chapter XIV Diseases of the genitourinary system,Other diseases of urinary system,27440,1551,1.07 [1.00-1.14],0.0432442736693223
BID,BH3-interacting domain death agonist,Chapter XIV Diseases of the genitourinary system,Other disorders of  bladder,26376,487,1.13 [1.01-1.27],0.0319110429013179
BID,BH3-interacting domain death agonist,Chapter XIV Diseases of the genitourinary system,Other disorders of breast,15276,68,0.82 [0.59-1.14],0.2374489350815792
BID,BH3-interacting domain death agonist,Chapter XIV Diseases of the genitourinary system,Other disorders of kidney and ureter,28270,322,1.01 [0.87-1.16],0.9096104646092752
BID,BH3-interacting domain death agonist,Chapter XIV Diseases of the genitourinary system,Other disorders of male genital organs,11227,157,0.89 [0.71-1.10],0.276877151985992
BID,BH3-interacting domain death agonist,Chapter XIV Diseases of the genitourinary system,Other disorders of penis,11190,120,1.09 [0.87-1.37],0.4496266294422013
BID,BH3-interacting domain death agonist,Chapter XIV Diseases of the genitourinary system,Other disorders of prostate,11148,78,0.94 [0.69-1.27],0.6724341080953308
BID,BH3-interacting domain death agonist,Chapter XIV Diseases of the genitourinary system,Other disorders of the genitourinary system,28284,54,1.03 [0.72-1.46],0.8812411012223487
BID,BH3-interacting domain death agonist,Chapter XIV Diseases of the genitourinary system,Other disorders of urethra and urinary system,27006,1117,1.05 [0.97-1.13],0.2029155463373186
BID,BH3-interacting domain death agonist,Chapter XIV Diseases of the genitourinary system,Other female pelvic inflammatory diseases,15150,123,1.08 [0.86-1.35],0.5242487016603
BID,BH3-interacting domain death agonist,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of cervix uteri,11522,91,1.08 [0.83-1.41],0.56175030645948
BID,BH3-interacting domain death agonist,Chapter XIV Diseases of the genitourinary system,"Other noninflammatory disorders of uterus, except cervix",11666,235,1.09 [0.93-1.29],0.29568961726976
BID,BH3-interacting domain death agonist,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vagina,11492,61,1.27 [0.93-1.73],0.132496452817037
BID,BH3-interacting domain death agonist,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vulva and perineum,11536,105,1.14 [0.90-1.46],0.2842046907716593
BID,BH3-interacting domain death agonist,Chapter XIV Diseases of the genitourinary system,Other obstructive and reflux uropathy,26811,266,1.13 [0.97-1.32],0.1120040806544588
BID,BH3-interacting domain death agonist,Chapter XIV Diseases of the genitourinary system,Other specified disorders of kidney and ureter,28062,114,1.04 [0.82-1.32],0.7666011651114453
BID,BH3-interacting domain death agonist,Chapter XIV Diseases of the genitourinary system,Ovarian cyst,11614,183,1.11 [0.92-1.34],0.2720930485161869
BID,BH3-interacting domain death agonist,Chapter XIV Diseases of the genitourinary system,Pain and other conditions associated with female genital organs and menstrual cycle,11514,83,1.22 [0.94-1.60],0.1370918776818512
BID,BH3-interacting domain death agonist,Chapter XIV Diseases of the genitourinary system,Polyp of the female genital tract,11875,444,1.02 [0.90-1.15],0.7559332520234211
BID,BH3-interacting domain death agonist,Chapter XIV Diseases of the genitourinary system,Postmenopausal atrophic vaginitis,11499,68,1.04 [0.76-1.43],0.7863483223546217
BID,BH3-interacting domain death agonist,Chapter XIV Diseases of the genitourinary system,Postmenopausal bleeding,11826,395,1.09 [0.96-1.24],0.1658008005258616
BID,BH3-interacting domain death agonist,Chapter XIV Diseases of the genitourinary system,Recurrent and persistent haematuria,28144,48,1.15 [0.81-1.65],0.4360066428003223
BID,BH3-interacting domain death agonist,Chapter XIV Diseases of the genitourinary system,"Redundant prepuce, phimosis and paraphimosis",11180,110,1.21 [0.96-1.51],0.1038338390667917
BID,BH3-interacting domain death agonist,Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,28112,1567,1.05 [0.99-1.12],0.1101257571090294
BID,BH3-interacting domain death agonist,Chapter XIV Diseases of the genitourinary system,"Tubulo-interstitial nephritis, not specified as acute or chronic",26692,147,1.15 [0.94-1.41],0.1795047753481973
BID,BH3-interacting domain death agonist,Chapter XIV Diseases of the genitourinary system,Unspecified kidney failure,26945,76,0.98 [0.73-1.32],0.8992803672482174
BID,BH3-interacting domain death agonist,Chapter XIV Diseases of the genitourinary system,Unspecified renal colic,27752,73,1.01 [0.75-1.37],0.9514324028763584
BID,BH3-interacting domain death agonist,Chapter XIV Diseases of the genitourinary system,Urethral stricture,26064,175,1.14 [0.95-1.38],0.1659835757076422
BID,BH3-interacting domain death agonist,Chapter XIV Diseases of the genitourinary system,Urolithiasis,28076,397,0.99 [0.87-1.13],0.892839596172915
BID,BH3-interacting domain death agonist,Chapter XIV Diseases of the genitourinary system,Uterine polyps,11536,105,1.09 [0.85-1.39],0.5095401240668829
